ALTERNATIVE FINANCING FORMS
FOR ENTREPRENEURS AND INVESTORS

Author: Tatjana Anderer

Gründerin des FYB-Verlag
News

Munich, London — Silver­fleet Capi­tal has gained another expe­ri­en­ced invest­ment specia­list in Ricardo Sommer (photo) . With him, the Euro­pean invest­ment company expands its invest­ment team specia­li­zing in smal­ler medium-sized compa­nies, led by Alex Breb­bia and David MacKen­zie. As Prin­ci­pal, Ricardo Sommer will in future be respon­si­ble for the invest­ment acti­vi­ties in the German-spea­king region, focu­sing on compa­nies with a value of between EUR 25 and 75 million. In addi­tion, he will support the acti­vi­ties of the Lower Mid-Market team in other regi­ons from the Munich office.

Ricardo Sommer comes from the invest­ment company Quadriga Capi­tal, where he played a key role as a direc­tor in buyouts of indus­trial compa­nies and busi­ness services provi­ders in the DACH region. Previously, Mr. Sommer worked as an invest­ment mana­ger for Synte­gra Capi­tal and advi­sed clients in the private equity and indus­trial goods sectors at the Boston Consul­ting Group. He studied indus­trial engi­nee­ring with a focus on mecha­ni­cal engi­nee­ring at the Tech­ni­cal Univer­sity of Berlin and holds an MBA from INSEAD.

David MacKen­zie, Part­ner at Silver­fleet Capi­tal and Co-Head of Lower Mid-Market, said, “We are plea­sed to welcome Ricardo Sommer on board. He brings exten­sive invest­ment expe­ri­ence to our team and will actively support us in further expan­ding our enga­ge­ment in the DACH region.”

About Silver­fleet Capital
Silver­fleet Capi­tal has been active as a private equity inves­tor in the Euro­pean mid-market for more than 30 years and curr­ently mana­ges around €1.2 billion with its 30-strong invest­ment team in Munich, London, Paris, Stock­holm and Amsterdam.

Eight invest­ments have alre­ady been made from the second inde­pen­dent fund closed in 2015 with a volume of 870 million euros: The Masai Clot­hing Company, a women’s fashion whole­sa­ler and retailer head­quar­te­red in Denmark; Coven­tya, a French deve­lo­per of specialty chemi­cals; Sigma Compon­ents, a U.K. manu­fac­tu­rer of precis­ion compon­ents for civil avia­tion; Life­time Trai­ning, a U.K. provi­der of trai­ning programs; Pumpen­fa­brik Wangen, a manu­fac­tu­rer of specialty pumps based in Germany; Riviera Travel, a British opera­tor of escor­ted group tours and crui­ses; 7days, a West­pha­lian supplier of medi­cal work­wear; and Prefere Resins, a leading phen­o­lic and amino resin manu­fac­tu­rer in Europe.

Silver­fleet achie­ves value growth through its “buy to build” invest­ment stra­tegy. As part of this stra­tegy, Silver­fleet is acce­le­ra­ting the growth of its subsi­dia­ries by inves­t­ing in new products, produc­tion capa­city and employees, instal­ling successful retail formats or making follow-up acqui­si­ti­ons. Since 2004, Silver­fleet Capi­tal has inves­ted €1.9 billion in 28 companies.

Silver­fleet specia­li­zes in four key indus­tries: Busi­ness and Finan­cial Services, Health­care, Manu­fac­tu­ring, and Retail and Consu­mer Goods. Since 2004, the private equity inves­tor has inves­ted 33 percent of its assets in compa­nies head­quar­te­red in the DACH region, 31 percent in the UK and Ireland, 19 percent in Scan­di­na­via and 17 percent mainly in France and the Bene­lux count­ries (1).

Silver­fleet Capi­tal has a solid invest­ment track record. Most recently, Silver­fleet sold Ipes, a leading provi­der of outsour­cing services to Euro­pean private equity firms (invest­ment multi­ple 3.8x); CCC, one of the leading BPO services provi­ders in Europe, as well as Cimbria, a Danish manu­fac­tu­rer of agri­cul­tu­ral equip­ment (2); Kalle, a German manu­fac­tu­rer of arti­fi­cial sausage pellets (invest­ment multi­ple 3.5x); OFFICE, a UK foot­wear retailer (invest­ment multi­ple 3.4x); and Aesica, a leading phar­maceu­ti­cal CDMO company (invest­ment multi­ple 3.3x).

News

Düssel­dorf - Commerz Real and the Swedish Ingka Group, as the largest share­hol­ders in a consor­tium, are each parti­ci­pa­ting in the project company of the Veja Mate offshore wind farm in the North Sea with more than 200 million euros. With a total of 67 wind turbi­nes and a total capa­city of 402 mega­watts, this is the second largest offshore wind farm in Germany and one of the ten largest farms in the world. Other part­ners are funds of the German invest­ment compa­nies KGAL Group and wpd invest. In total, the consor­tium is acqui­ring around 80 percent of the shares in the project company.

Toge­ther with the debt capi­tal, the tran­sac­tion volume amounts to around €2.3 billion. The sellers of the park, which has been in opera­tion since 2017, are the previous project deve­lo­pers and owners High­land Group Holdings, Copen­ha­gen Infra­struc­ture Part­ners and Siemens Finan­cial Services. The latter will conti­nue to hold 20 percent of the shares. Tech­ni­cal support is provi­ded by Siemens Gamesa Rene­wa­ble Energy under a full-service contract.

Veja Mate is loca­ted about 95 km northwest of the island of Borkum in the German econo­mic zone of the North Sea and covers an area of 51 square kilo­me­ters. In this area, the average wind speed is more than 10 meters per second. The 180-meter-high wind turbi­nes have rotors each 154 meters in diame­ter and their foun­da­ti­ons are 7.8 meters in diame­ter. At 84.5 meters in length, they are the largest of their kind manu­fac­tu­red to date. The turbi­nes are desi­gned for an opera­ting life of 25 years, the main­ten­ance contract with Siemens initi­ally runs for 15 years. Accor­ding to the Rene­wa­ble Energy Sources Act (EEG 2014), the feed-in tariff is to be paid for a total of 20 years, until 2037. Accor­ding to the opera­tors, the opera­tion of the wind farm will save around 950,000 tons of carbon dioxide per year.

The consor­tium, consis­ting of the IRI Invest­ments BV, a subsi­diary of the Swedish Ingka Group, ANET GmbH & Co. Geschlos­sene Invest­ment KG, KGAL ESPF 4 Holding SARL, ALH Euro­pean Infra S.C.S. SICAV-RAIF and the Green Return Fund 3 S.C.S. SICAV-FIAR, prevai­led in a bidding process. The invest­ment was acqui­red by way of a share deal from the sellers Siemens Project Venture GmbH, High­land Capi­tal Group and Copen­ha­gen Invest­ment Part­ners. The consor­tium was advi­sed in the bidding process by Watson Farley & Williams LLP.

About IRI Invest­ments BV
IRI Invest­ments BV is an invest­ment company of the Ingka Group that invests, among other things, in rene­wa­ble energy projects.

Advi­sors to IRI Invest­ments BV: Luther Rechtsanwaltsgesellschaft
Luther, Corpo­rate / M&A, Düssel­dorf: Marc Urlichs (Coun­sel, Lead)
Luther, Energy Law, Düssel­dorf: Dr. Angelo Vallone (Part­ner)
The Luther team led by Coun­sel Marc Urlichs advi­sed IRI Invest­ments BV both in connec­tion with the ente­ring into and struc­tu­ring of the consor­tium and in connec­tion with the nego­tia­ti­ons with the sellers.

News

Munich, Frank­furt, Zurich ‑Despite strong first half, only 89 LBO finan­cings in 2018 — first decline since 2012. After years of steady growth, the German LBO market has recor­ded a decline for the first time since the end of the finan­cial crisis. The number of comple­ted tran­sac­tions fell to 89 last year compared with 103 in 2017 — a drop of almost 15 percent. Alter­na­tive finan­ciers, on the other hand, contin­ued their success story unde­ter­red in 2018, defy­ing the gene­ral decline in the German LBO market. The market share of debt funds rises to almost 50 percent.

The current MidCap­Mo­ni­tor of the invest­ment bank GCA Altium, which regu­larly pres­ents lever­a­ged buyout finan­cings with a loan volume of between 20 and 500 million euros, shows for the In 2018 as a whole, debt funds accoun­ted for almost half of the German LBO market: At 35 percent, it has again increased signi­fi­cantly compared with 2017 and now amounts to 48 percent. Of the 89 tran­sac­tions in 2018, Debt Funds successfully execu­ted 43 tran­sac­tions. The banks’ market share was still 65 percent in 2017 and has now shrunk to 52 percent with 46 transactions.

The success of alter­na­tive finan­cing parties is based on seve­ral factors. On the one hand, it can be obser­ved that banks are beco­ming more risk-averse in indi­vi­dual tran­sac­tions — espe­ci­ally with cycli­cal compa­nies. More flexi­ble debt funds fill this gap, secu­ring tran­sac­tions that would not have been finan­ced with banks — or only much more conser­va­tively. On the other hand, a signi­fi­cantly increased number of debt funds can now provide volu­mes of EUR 150 million and more per indi­vi­dual tran­sac­tion, making a complex banking club super­fluous. “The time advan­tage of larger, single-source finan­cings now plays a parti­cu­larly frequent role in compe­ti­tive auctions,” comm­ents Johan­nes Schmit­tat, Mana­ging Direc­tor in GCA Altium’s Frank­furt office. It can also be obser­ved that buy-and-build stra­te­gies in parti­cu­lar are being finan­ced via alter­na­tive lenders. “The final matu­rity of the loans, as well as grea­ter flexi­bi­lity in terms, frees up capi­tal for growth through acqui­si­ti­ons,” says Norbert Schmitz, also a mana­ging direc­tor at GCA Altium.

It is also striking that the success of alter­na­tive finan­cing parties is not limi­ted to Germany. Across Europe, 219 LBO tran­sac­tions were finan­ced by debt funds last year. “Compared to 2017, that’s another 22 percent increase,” says Norbert Schmitz. Howe­ver, Q4 saw the first signi­fi­cant quar­ter-on-quar­ter decline of 14 tran­sac­tions (down 23 percent). In addi­tion to Germany with 43 tran­sac­tions, alter­na­tive finan­cing was also used inten­si­vely in the UK (67 tran­sac­tions) and France (48 transactions).

Over­all, GCA Altium does not expect banks to regain lost market share in the near future. On the contrary, a further increase in alter­na­tive finan­cing is expec­ted in 2019.

On the banking side, Commerz­bank contin­ued its successful first half of the year, ranking first for 2018 as a whole with 13 transactions.
Unicre­dit (10) was able to defend its 2nd place, whereas last year’s market leader SEB (9) has to share 3rd place with Bayern LB (9). It is note­wor­thy here that the number of tran­sac­tions finan­ced by banks recor­ded a decrease of 32 percent and, at 46 in 2018, is signi­fi­cantly below the level of 2017 (68).

Even though the London large-cap and high-yield market faced fierce head­winds for low margins and very borrower-friendly terms seve­ral times in 2018, GCA Altium did not see any impact on the German LBO market. “Due to the contin­ued extre­mely compe­ti­tive envi­ron­ment between banks and debt funds, we expect stable condi­ti­ons in the short term,” adds Norbert Schmitz.

About GCA Altium
GCA Altium is the Euro­pean divi­sion of GCA. The global invest­ment bank provi­des stra­te­gic M&A as well as capi­tal markets advi­sory services to growth compa­nies and market leaders. GCA opera­tes globally with over 400 experts in 18 loca­ti­ons in the US, Asia and Europe. Built by the people who run the busi­ness, GCA specia­li­zes in deals that require commit­ment, an unbi­a­sed view, exper­tise and unique networks. www.gcaaltium.com

News

Frank­furt / Munich — The Smal­ler Mid-Cap Fund ( “TSM ”) advi­sed by Triton (“Triton ”) has comple­ted its invest­ment in Deut­sche Radio­lo­gie Holding (“DRH”). TSM is inves­t­ing along­side exis­ting inves­tors, the owners of Tempus Capi­tal and DRH Manage­ment. Terms of the tran­sac­tion were not disc­lo­sed. Gibson, Dunn & Crut­cher LLP advi­sed the Triton Smal­ler Mid-Cap fund on the transaction.

DRH was foun­ded in 2017 and offers flexi­ble and profes­sio­nal succes­sion solu­ti­ons to radio­lo­gists and radia­tion thera­pists. The company is a strong and expe­ri­en­ced part­ner for successful owners. DRH’s expe­ri­en­ced team ensu­res a tech­ni­cally compe­tent and relia­ble hando­ver process, as well as the long-term secu­rity of the owners’ work.

The Triton Smal­ler Mid-Cap Fund invests in mid-cap compa­nies in the indus­trial, services, consu­mer goods and health­care sectors.

About Triton
Since its foun­ding in 1997, Triton has laun­ched nine funds and focu­sed on compa­nies in the indus­trial, services, consu­mer goods and health­care sectors.The Triton funds invest in medium-sized compa­nies based in Europe and support their posi­tive deve­lo­p­ment. Triton’s goal is to successfully deve­lop its port­fo­lio compa­nies in the long term by working toge­ther as part­ners. Triton and its manage­ment strive to gene­rate posi­tive change and growth through the sustainable impro­ve­ment of opera­tio­nal proces­ses and struc­tures. At present, Triton’s port­fo­lio includes 37 compa­nies with total sales of around EUR 13 billion and around 84,000 employees.

The Gibson Dunn team, led by Frank­furt-based corpo­rate part­ner Dr. Wilhelm Rein­hardt (photo ) and Munich-based finance part­ner Sebas­tian Schoon, included Dr. Dirk Ober­bracht (part­ner, corpo­rate, Frank­furt), Dr. Jens-Olrik Murach (part­ner, anti­trust, Frank­furt and Brussels), Alex­an­der Klein (of coun­sel, finance, Frank­furt) and Dr. Milena Volk­mann (asso­ciate, corpo­rate, Frankfurt).

About Gibson Dunn
Gibson, Dunn & Crut­cher LLP is one of the leading inter­na­tio­nal law firms and is ranked among the top law firms world­wide in indus­try surveys and by autho­ri­ta­tive publi­ca­ti­ons. With more than 1,300 lawy­ers in 20 offices, the firm has a global presence in all major econo­mic regi­ons. Gibson Dunn offices are loca­ted in Brussels, Century City, Dallas, Denver, Dubai, Frank­furt, Hong Kong, Hous­ton, London, Los Ange­les, Munich, New York, Orange County, Palo Alto, Paris, Beijing, San Fran­cisco, São Paulo, Singa­pore and Washing­ton, D.C. For more infor­ma­tion, visit www.gibsondunn.com.

News

Hamburg — Five months after the offi­cial launch of the inde­pen­dent online compa­ri­son plat­form for invest­ment products, the company has now secu­red the support of well-known inves­tors and over 3.3 million euros in equity capi­tal for the further deve­lo­p­ment of the online plat­form in a first round of financing.

“We want to give ever­yone inde­pen­dent access to the best and most rele­vant invest­ment products,” says Phil­ipp Schrö­der, CEO of the plat­form. Curr­ently, CAPin­side provi­des its auto­ma­ted real-time compa­ri­sons of over 40,000 invest­ment products as well as their ratings for profes­sio­nal inves­tors free of charge. Thus, the fintech from Hamburg offers the best possi­ble decis­ion support for investors.

“There is hardly an indus­try that has dama­ged itself so much through syste­ma­tic intrans­pa­rency and which, at the same time, is still so little digi­ti­zed as the invest­ment indus­try. And this is despite the fact that invest­ment funds are actually comple­tely unri­va­led as a form of invest­ment due to histo­ri­cally low inte­rest rates,” says Schrö­der, who successfully promo­ted the digi­tiza­tion and demo­no­po­liza­tion of the energy indus­try before foun­ding CAPin­side. “CAPin­side aims to regain trust through trans­pa­rency by deve­lo­ping our compa­ri­son tech­no­logy to help private inves­tors make better and more infor­med finan­cial decis­i­ons in the future,” Schrö­der said.

To ensure this, CAPin­side has now raised fresh capi­tal and will launch a compa­ri­son plat­form in April 2019 that can also be used by non-profes­sio­nal inves­tors. The capi­tal round was led by Thomas Pütter, the well-known venture capi­ta­list and ex-CEO of Alli­anz Capi­tal Part­ners, who also chairs the super­vi­sory board of CAPin­side AG. The inves­tors conti­nue to include Andreas Kupke, co-foun­der of Finanzcheck.de, Chris­toph Oster­mann, foun­der and CEO of the tech­no­logy start-up sonnen, and Alex­an­der Holt­ap­pels, CEO and foun­der of the Hamburg-based soft­ware company SABIO.

Since Septem­ber 2018, over 7,000 profes­sio­nal users have regis­tered with CAPinside.com and over 2 million non-regis­tered users visit the site per month. www.capinside.com

News

Zurich (CH) — The “Swiss Entre­pre­neurs Fund” has been laun­ched by Swis­sEF toge­ther with the insurer Mobi­liar and the major banks UBS and Credit Suisse, the foun­da­tion announ­ced on Thurs­day. The first inves­tor is Mobi­liar, which is contri­bu­ting CHF 100 million.

The Finan­cial Market Autho­rity Finma appro­ved the fund at the end of Janu­ary. — This would allow the fund to be opened up to the target size of CHF 500 million over the next few months. The initia­tors hope that insti­tu­tio­nal inves­tors such as pension funds, family offices and wealthy private indi­vi­du­als will also invest in the fund.
The fund aims to invest directly, but also via third-party funds, in inno­va­tive compa­nies with growth poten­tial. The majo­rity of the invest­ments are to be made in compa­nies that have their head­quar­ters or a “signi­fi­cant share of their value crea­tion” in Switzerland.

Invest­ment focus of the Allied Banks
What is unique is that the two big banks were jointly invol­ved in an invest­ment vehicle, accor­ding to Swis­sEF. UBS contri­bu­tes its exper­tise in venture capi­tal and private equity funds. On the one hand, it invests in estab­lished invest­ment mana­gers, but also selec­tively promo­tes the forma­tion of new private equity funds. Credit Suisse, on the other hand, will be respon­si­ble for direct invest­ments in start­ups and inno­va­tive SMEs.
The target is for 50 to 66 percent of invest­ments to flow into Swiss compa­nies, with invest­ments also to be made prima­rily in compa­nies from neigh­bor­ing count­ries. Direct invest­ments are to amount to at least 20 percent of total invest­ments, and 65 to 80 percent of the funds will be inves­ted in third-party funds. The fund money is to be allo­ca­ted in a balan­ced way at diffe­rent stages of deve­lo­p­ment, i.e. in venture capi­tal, in invest­ments in fast-growing compa­nies and in small to medium-sized “buyouts”.

Startup loca­tion Switzerland
The Swiss Entre­pre­neurs Foun­da­tion, which is supported by the private and poli­ti­cal sectors, was laun­ched in Decem­ber 2017 under the patro­nage of then-Fede­ral Coun­cilor Johann Schnei­der-Ammann to address the “chal­lenges facing Switz­er­land as a loca­tion for inno­va­tion and start­ups”. The foun­da­tion, based in Bern, has been under the patro­nage of Fede­ral Coun­cil­lor and head of the EAER Guy Parme­lin since the begin­ning of 2019. Johann Schnei­der-Ammann will remain asso­cia­ted with Swis­sEF as Hono­rary President.

The foundation’s goal is for Switz­er­land to expand its “leading posi­tion as a loca­tion for busi­ness and inno­va­tion” and create new jobs. In doing so, it intends to take a two-pron­ged approach. In addi­tion to the Swiss Entre­pre­neur Fund, which is now being presen­ted, it also imple­ments projects aimed at impro­ving the frame­work condi­ti­ons for entre­pre­neur­ship and inno­va­tive technologies.

Last year, he said, the foun­da­tion had alre­ady laun­ched two projects. The “Swis­sEF UpSca­ler” program is inten­ded to provide compa­nies in the growth phase with a “tailor-made support program”. A team from a pool of 50 expe­ri­en­ced “top entre­pre­neurs” and experts assist such compa­nies. In the “Swis­sEF Shaper” program, entre­pre­neurs are to be brought into cont­act with repre­sen­ta­ti­ves from natio­nal poli­tics and sensi­tize them to their concerns. www.swissef.ch

News

Stockholm/Berlin — Wine in Black, one of the leading online stores for high-quality wines in Germany, France, the Nether­lands, Austria and Switz­er­land, beco­mes part of the Swedish Viva Group, one of Scandinavia’s largest wine importers. Viva Group plans to further streng­then its growth trajec­tory with the Berlin-based retailer’s e‑commerce capa­bi­li­ties, while Wine in Black will bene­fit from the Swedish market leader’s global supplier rela­ti­onships. The acqui­si­tion alre­ady took place in Q4 2018 and will be formally closed in the coming weeks.

Emil Sall­näs, Mana­ging Part­ner of Viva Group: “Wine in Black has estab­lished a unique posi­tion in some of the largest and most attrac­tive Euro­pean markets for premium wines. We look forward to working with the Wine in Black team in Berlin and our teams in Scan­di­na­via to further acce­le­rate Wine in Black’s growth.”

Wine in Black was foun­ded in 2011. Foun­der and mana­ging direc­tor Stephan Linden (photo on the right) will leave the company after a tran­si­tio­nal phase in mid-2019 to devote hims­elf to new entre­pre­neu­rial projects. Wine in Black will be led by Chris­tian Fricke (photo left), who alre­ady joined Wine in Black as Mana­ging Direc­tor in Febru­ary 2018, and will conti­nue to act entre­pre­neu­ri­ally auto­no­mous and independent.

Stephan Linden: “As a start-up in a very compe­ti­tive market, we were very fort­u­nate to be able to attract such expe­ri­en­ced and successful venture capi­ta­lists as Project A, e.ventures, btov, Black River Ventures and others. After we were able to deve­lop Wine in Black from zero to an eight-digit annual turno­ver, it is now exactly the right time to start the next growth phase of Wine in Black with a stra­te­gic part­ner. The Swedish Viva Group convin­ced us with its very entre­pre­neu­rial approach, global network and deep market under­stan­ding and will help Chris­tian and the manage­ment team to take Wine in Black to the next level.”

Chris­tian Fricke: “Wine in Black star­ted as a closed shop­ping club for premium wines. In the past two years, the model has under­gone major deve­lo­p­ment. Our custo­mers appre­ciate our cura­ted and ever-chan­ging assort­ment to find exci­ting wines and further expand their know­ledge of wine. As a plat­form, we want to become the first port of call for anyone who wants to disco­ver new, high-quality wines. Viva Group shares our vision for the further deve­lo­p­ment of Wine in Black and will support us as a stra­te­gic part­ner in the further expan­sion in our core markets and beyond with a very long-term perspec­tive. I am very happy
about the new oppor­tu­ni­ties that this strong part­ner will create for the entire team and our market partners.”

Consul­tant Wine in Black GmbH:Vogel Heerma Waitz
Olga Balan­dina-Luke advi­sed Berlin-based online wine retailer Wine in Black GmbH on its acqui­si­tion by Scandinavia’s largest wine importer Viva Group.

About Viva Group
Over the past 20 years, Viva Group (www.vivagroup.se) has become the largest importer of wine and spirits in Scan­di­na­via. Through its subsi­dia­ries Chris Wine & Spirits, Giertz Vinim­port, The Wine Team, Wine­mar­ket and Iconic Wines, the company has a market share of nearly 25% at Systembo­la­get, the Swedish retail mono­poly. Inter­na­tio­nally, Viva Group is present with subsi­dia­ries in Finland, Norway, China and the UK. The Viva Group is also alre­ady repre­sen­ted in Germany by its life­style-orien­ted online store Wine a Porter.

About Wine in Black
Wine in Black is a leading online store for premium wine with a constantly chan­ging assort­ment of 300 wines at an average bottle price of 15 euros. The company is active in Germany, France, the Nether­lands, Austria and Switz­er­land. Wine in Black was foun­ded in 2011 and funded by leading Euro­pean venture capi­tal inves­tors, inclu­ding Project A Ventures, Black River Ventures, e.ventures, Bright Capi­tal, Passion Capi­tal, btov, KFW, Keen Mind Ventures, and kaufDA / Bonial Inter­na­tio­nal Group foun­ders Chris­tian Gaiser and Tim Marbach. For more infor­ma­tion about Wine in Black, visit http://www.wine-in-black.de.

News

London — H.I.G. Capi­tal, a leading global private equity firm with over EUR 26 billion in equity under manage­ment, appoints Markus Noe-Nord­berg (photo) as Mana­ging Direc­tor and head of its new Euro­pean mid-cap busi­ness, which will comple­ment H.I.G.’s exis­ting Euro­pean small-cap activities.

The small-cap team focu­sing on medium-sized compa­nies with an enter­prise value of up to EUR 250 million will conti­nue to invest from the current EUR 825 million fund as before.

Markus Noe-Nord­berg will lead the private equity acti­vi­ties in the mid-cap segment from London and work closely with the estab­lished local invest­ment teams. He has over 30 years of expe­ri­ence in corpo­rate finance and leverage buyout. Prior to joining H.I.G. Capi­tal, he was a part­ner and one of the foun­ders of Pamplona Capi­tal. Previously, he was a Mana­ging Direc­tor and Co-Head in the Finan­cial Spon­sors Group at Gold­man Sachs in London.

Sami Mnaym­neh and Tony Tamer, foun­ders and co-CEOs of H.I.G., commen­ted, “We are very plea­sed to have Markus join H.I.G.. Given his back­ground and expe­ri­ence, he is the ideal fit to lead our new private equity acti­vi­ties in the Euro­pean mid-cap segment.”

Commen­ting on his new role, Noe-Nord­berg said: “I am deligh­ted to build on H.I.G.’s success in Europe in the small-cap and lower mid-cap markets, where the firm has alre­ady secu­red a leading posi­tion in private equity with five offices. We are now broa­de­ning our invest­ment focus to include larger tran­sac­tions valued between EUR 250 million and EUR 750 million — a market segment in which the firm has been a successful player in the U.S. for more than a decade.”

About H.I.G. Capital
H.I.G. is a leading global alter­na­tive asset invest­ment firm with over EUR 26 billion in equity under manage­ment.* The company is head­quar­te­red in Miami and has U.S. offices in New York, Boston, Chicago, Dallas, Los Ange­les, San Fran­cisco and Atlanta, as well as inter­na­tio­nal branch offices in London, Hamburg, Madrid, Milan, Paris, Bogotá, Rio de Janeiro and São Paulo. H.I.G. specia­li­zes in the provi­sion of debt and equity capi­tal to small and medium-sized compa­nies, pursuing a flexi­ble, opera­tio­nally orien­ted and value-enhan­cing approach:

1. H.I.G. invest­ment funds invest in manage­ment buyouts, corpo­rate reor­ga­niza­ti­ons, and spin-offs of both profi­ta­ble and distres­sed manu­fac­tu­ring and service companies.
2. H.I.G.’s debt funds invest in senior, unitran­che and subor­di­na­ted debt finan­cing tran­sac­tions with compa­nies of all sizes, both directly and through secon­dary markets. In addi­tion, H.I.G. is a leading CLO mana­ger through its White­Horse port­fo­lio and mana­ges a publicly traded BDC through White­Horse Finance.
3. H.I.G. real estate funds invest in upgraded proper­ties that can bene­fit from better asset manage­ment methods.

Since its foun­ding in 1993, H.I.G. has inves­ted in and mana­ged over 300 compa­nies world­wide. The company’s port­fo­lio curr­ently includes over 100 compa­nies with combi­ned total reve­nues of over €28 billion. For more infor­ma­tion, visit H.I.G.’s website at www.higcapital.com.

* Based on total capi­tal commit­ments mana­ged by H.I.G. Capi­tal and part­ner firms.

News

Frank­furt am Main — Last year, company foun­ders and fami­lies among the sellers of compa­nies to finan­cial inves­tors reached a new record high of around 40 percent, the highest share ever recor­ded. 19 of 47 manage­ment buyouts (MBOs) in the mid-market segment of the German buyout market were succes­sion solu­ti­ons in 2018. This is a further increase on the previous two years, which alre­ady saw above-average levels of family buyouts. In previous years, barely more than one in ten tran­sac­tions had a family background.

“Foun­ders and family entre­pre­neurs are incre­asingly reco­gni­zing the contri­bu­tion that finan­cial inves­tors can make to the further deve­lo­p­ment of their compa­nies,” said Tors­ten Grede, Spokes­man of the Manage­ment Board of DBAG. He conti­nues, “We are now seeing more and more entre­pre­neurs seeking new share­hol­ders with new busi­ness models in promi­sing indus­tries — so the market is broa­de­ning for us.”

There was also a signi­fi­cant increase in buyout acti­vity over­all. With 47 tran­sac­tions, finan­cial inves­tors struc­tu­red 12 more MBOs in the German SME sector last year than in 2017. This is also a new record for this market segment since Deut­sche Betei­li­gungs AG (DBAG) began evalua­ting it in 2002. In almost every second tran­sac­tion (21 out of 47), finan­cial inves­tors were active on both sides, i.e. as sellers and buyers. Spin-offs from groups or conglo­me­ra­tes were again the excep­tion in 2018, with seven cases.

The analy­sis only takes into account tran­sac­tions in which finan­cial inves­tors have acqui­red a majo­rity stake in a company with manage­ment parti­ci­pa­tion and which have a tran­sac­tion value for the debt-free company of between 50 and 250 million euros. This is based on publicly available sources as well as esti­ma­tes and rese­arch by DBAG in coope­ra­tion with FINANCE.

Last year, private equity compa­nies finan­ced buyouts in the German SME sector worth a good 4.8 billion euros. This is the highest value since 2002, when the evalua­tion began; in 2017, the market volume had amoun­ted to 4.4 billion euros. The average enter­prise value decreased from 126 million euros to 103 million euros. Unlike in 2017, the vast majo­rity of tran­sac­tions (30 out of 47) were now in the lower part of the segment (enter­prise value: €50 million to €100 million). This corre­sponds to the high propor­tion of company foun­ders among the sellers: Of the 19 MBOs in which finan­cial inves­tors repla­ced fami­lies as share­hol­ders, 13 were dispo­sals by the company foun­der. As in the previous year, around half of the tran­sac­tions (24 out of 47) were struc­tu­red by multi­na­tio­nal, pan-Euro­pean private equity funds.

Deut­sche Betei­li­gungs AG is repre­sen­ted in the list of buyouts with three MBOs in 2018. It is thus once again one of the most active finan­cial inves­tors for private equity in the market segment under conside­ra­tion. In the past 15 years, DBAG accoun­ted for 27 tran­sac­tions, more than any other finan­cial investor.

Family offices are incre­asingly percei­ved as real competition
Despite the larger market volume, compe­ti­tion in the German SME buyout market is intense. This is because the supply of capi­tal is also growing. In addi­tion to the well-known private equity compa­nies focu­sing on invest­ments in German SMEs, there are other compa­nies that are laun­ching funds for invest­ments in this segment on the market for the first time. Added to this is the capi­tal of multi­na­tio­nal private equity funds, which are also targe­ting the German market. Available capi­tal will conti­nue to exceed invest­ment oppor­tu­ni­ties in 2019.

In addi­tion to the abun­dant supply of capi­tal, private equity firms face growing compe­ti­tion from family offices. Just how strong is shown by the current survey of invest­ment mana­gers from more than 50 private equity houses opera­ting in Germany, who are polled every six months on behalf of DBAG by the trade maga­zine FINANCE about trends in the German midmar­ket segment. 72 percent of them — leaving stra­te­gic buyers aside for the moment — recently saw family offices as the biggest compe­ti­tion outside the private equity camp. A year ago, only 59 percent did so. More than 80 percent of respond­ents agreed with the thesis that family offices have made life diffi­cult for private equity inves­tors in the battle for medium-sized take­over targets in the past 12 to 24 months. These figu­res suggest that at least those family offices that have estab­lished private equity-stan­dard struc­tures have caught up with the estab­lished PE houses. Thus, family offices are not only percei­ved as compe­ti­tors in bila­te­ral discus­sions with sellers of medium-sized compa­nies, but almost as much in auctions.

Accor­ding to the survey, compe­ti­tion among the port­fo­lio compa­nies is rated at 8.4 on a scale of 1 (very low) to 10 (very high) — this assess­ment has hardly chan­ged in the past three years.

DBAG trig­gers equity invest­ments of over 270 million euros in 2018
In 2018, Deut­sche Betei­li­gungs AG struc­tu­red eight manage­ment buyouts for the funds it advi­ses: Three of these, namely the MBOs of the mecha­ni­cal and plant engi­nee­ring compa­nies Karl Eugen Fischer GmbH and Kraft & Bauer GmbH as well as the auto­mo­tive supplier Sero Schrö­der Elek­tro­nik Rohr­bach GmbH, were included in the statis­tics mentio­ned at the begin­ning. the five other MBOs are attri­bu­ta­ble to other market segments. DBAG trig­ge­red equity invest­ments of around 270 million euros for this purpose. It has two funds at its dispo­sal for invest­ments in the midmar­ket: DBAG Fund VII — the largest German private equity fund for invest­ments in the midmar­ket, with commit­ments of one billion euros — can deploy up to 200 million euros of equity per tran­sac­tion; more than 50 percent of the fund’s resour­ces are commit­ted a good two years after the start of the invest­ment. The DBAG ECF invests majo­rity or mino­rity inte­rests in compa­nies with a smal­ler enter­prise value; it focu­ses prima­rily on owner-mana­ged medium-sized compa­nies and offers a high degree of flexi­bi­lity with regard to the invest­ment ratio or holding period, which is parti­cu­larly important for entre­pre­neurs, via a broad range of finan­cing forms.

Value enhance­ment of sophisticated
Despite the recent dyna­mic deve­lo­p­ment of the buyout market, DBAG does not expect a further increase in the number of mid-market MBOs in 2019. “Macroe­co­no­mic uphe­avals, such as those caused by Brexit and trade conflicts, increase uncer­tainty — this can affect pricing in the M&A busi­ness and market dyna­mics,” said board spokes­man Grede. “For the exis­ting port­fo­lio, the chall­enge of selec­ting and imple­men­ting value-enhan­cing stra­te­gies — such as expan­ding the product range or ente­ring new geogra­phic markets — remains significant.”

Further infor­ma­tion and the full results of the market survey and market statis­tics, inclu­ding the complete list of MBOs in the German Mittel­stand, are available on DBAG’s website (www.dbag.de).

About Deut­sche Betei­li­gungs AG
Deut­sche Betei­li­gungs AG, a listed company, initia­tes closed-end private equity funds and invests along­side DBAG funds in well-posi­tio­ned medium-sized compa­nies with deve­lo­p­ment poten­tial. DBAG focu­ses on indus­trial sectors in which German SMEs are parti­cu­larly strong by inter­na­tio­nal stan­dards. With this expe­ri­ence, know-how and equity, it streng­thens the port­fo­lio compa­nies in imple­men­ting a long-term, value-enhan­cing corpo­rate stra­tegy. The entre­pre­neu­rial invest­ment approach makes DBAG a sought-after invest­ment part­ner in the German-spea­king region. The capi­tal mana­ged and advi­sed by the DBAG Group amounts to appro­xi­m­ately 1.8 billion euros.

News

Munich — ARQIS advi­sed Seki­sui Plas­tics Europe GmbH, Munich, on the acqui­si­tion of a 75 percent stake in Proseat GmbH & Co KG, Mörfel­den-Wall­dorf, and seven other Proseat compa­nies from Recti­cel NV/SA, Belgium.

Proseat was foun­ded in 1999 as a joint venture between Recti­cel and its Cana­dian part­ner Wood­bridge Foam Corpo­ra­tion. The company supplies direct suppli­ers (Tier 1) and origi­nal equip­ment manu­fac­tu­r­ers (OEM) in the auto­mo­tive indus­try with molded seat cushions and head and armrests made of poly­ure­thane. The Proseat Group consists of eight compa­nies in six Euro­pean count­ries (Germany, France, Great Britain, Poland, Spain and the Czech Repu­blic). It occu­p­ies a leading posi­tion as Europe’s largest inde­pen­dent manu­fac­tu­rer of parts (seat uphols­tery mate­rial, trim parts such as head­rests and armrests, and foamed molded parts) for Euro­pean auto­mo­tive compa­nies. The auto­mo­tive indus­try is curr­ently under­go­ing signi­fi­cant change, charac­te­ri­zed by self-driving cars and elec­tric vehic­les. In auto­mo­tive parts, there is a growing need for mate­ri­als that help reduce envi­ron­men­tal impact, such as weight reduc­tion and ther­mal insulation.

ARQIS’ advi­sory services included assis­tance with legal due dili­gence in a total of seven juris­dic­tions, struc­tu­ring, and contract draf­ting and nego­tia­tion. ARQIS led an inter­na­tio­nal and multi­di­sci­pli­nary legal team consis­ting of Cuat­re­ca­sas (Spain), Dentons (Czech Repu­blic, Poland), Gide (France), Nauta­Du­tilh (Belgium) and RPC (UK), as well as Held Jagut­tis (Public Commer­cial Law/Regulatory) and RCAA (Anti­trust).

Advi­sors to Seki­sui Plas­tics: ARQIS Rechts­an­wälte (Düsseldorf/Munich)
Prof. Dr. Chris­toph von Einem (photo), Dr. Shigeo Yama­guchi (both lead); Eber­hard Hafer­malz, Dr. Meiko Dill­mann, Dr. Lars Laeger (all Corporate/M&A), Dr. Andrea Panzer-Heemeier (Labor Law), Dr. Ulrich Lien­hard (Real Estate), Marcus Noth­hel­fer (IP & Commer­cial; Munich), Dr. Mirjam Boche (W&I Insu­rance). Coun­sel: Dr. Phil­ipp Maier (IP & Commer­cial; Munich). Asso­cia­tes: Mauritz von Einem (Lead Asso­ciate; Corporate/M&A/Tax), Dr. Florian Kotman, Elisa­beth Falte­rer (Munich) (both Corporate/M&A), Dr. Hendrik von Mellen­thin, Dr. Markus Schwip­per (Munich) (both Labor Law), Jenni­fer Danisch (Real Estate).

About ARQIS
ARQIS is an inde­pen­dent busi­ness law firm opera­ting in Germany and Japan. The firm was foun­ded in 2006 at its current offices in Düssel­dorf, Munich and Tokyo. Around 45 profes­sio­nals advise dome­stic and foreign compa­nies at the highest level on the core issues of German and Japa­nese busi­ness law. The focus is on M&A, corpo­rate law, private equity, venture capi­tal, employ­ment law, private clients, intellec­tual property, liti­ga­tion as well as real estate law and tax law.

News

Munich — Munich-based invest­ment holding PRIMEPULSE SE has acqui­red all shares in ETL Elek­tro­tech­nik Lauter GmbH (“ETL”), one of Germany’s most advan­ced EMS (elec­tro­nic manu­fac­tu­ring services) provi­ders. The company, based in Mauer­stet­ten (Allgäu), streng­thens the acti­vi­ties of the PRIMEPULSE Group in the EMS sector, which alre­ady includes in parti­cu­lar the Katek Group of Compa­nies, Gras­sau, and Steca Elek­tro­nik, Memmin­gen. Both within the divi­sion and across the entire network, the inte­gra­tion of ETL and access to the know-how and resour­ces of the powerful PRIMEPULSE network will result in nume­rous synergies.

ETL employs 180 people and has a turno­ver of around 40 million euros. The service and solu­tion exper­tise covers the entire life cycle of elec­tro­nic assem­blies and devices, from deve­lo­p­ment support to mate­ri­als and project manage­ment, produc­tion and logi­stics, and after-sales service. ETL’s custo­mers are active in the medi­cal tech­no­logy, indus­try, avia­tion, sensor tech­no­logy, safety tech­no­logy and rail­road tech­no­logy sectors, among others.

Klaus Wein­mann, CEO of PRIMEPULSE SE: “We see that busi­ness in the EMS sector is influen­ced by trends such as IoT and embedded compu­ting as well as the rapid deve­lo­p­ment of new tech­no­lo­gies. Against the back­ground of nume­rous, new appli­ca­ti­ons and services due to digi­ta­liza­tion, the EMS market promi­ses very high growth poten­tial. ETL is tech­ni­cally at a very high level, espe­ci­ally in the IoT area. Moreo­ver, with ETL we gain an estab­lished company with a first-class repu­ta­tion in the elec­tro­nics envi­ron­ment in addi­tion to an expe­ri­en­ced and moti­va­ted manage­ment team.”

For the tech­no­logy-orien­ted PRIMEPULSE group of compa­nies, the acqui­si­tion of ETL is a further consis­tent step in its ambi­tious growth stra­tegy on the way to beco­ming one of the top 3 German EMS service provi­ders. The strong compe­ten­cies of the port­fo­lio compa­nies in the two PRIMEPULSE busi­ness areas of Tech­no­logy and Indus­try, along with targe­ted acqui­si­ti­ons, are the drivers of the Group’s dyna­mic growth. Thus, PRIMEPULSE is aiming to exceed one billion in sales for the Group this fiscal year with over 4,300 employees in the conso­li­da­ted companies.

About Prime­im­pulse SE
Prim­e­pulse SE is an invest­ment holding company based in Munich, Germany, which specia­li­zes in invest­ments in tech­no­logy-orien­ted compa­nies in promi­sing markets. The Prim­e­pulse Tech­no­logy port­fo­lio includes the topics Indus­try 4.0, Auto­ma­tion and Inter­net of Things. As a stra­te­gic part­ner, Prim­e­pulse actively supports its group compa­nies in their growth.

Advi­sor to Prim­e­pulse SE: Heuking Kühn Lüer Wojtek
Boris Dürr, Daniela Szczesny (both M&A/Corporate, both lead)
Chris­tian Schild, LL.M. (M&A/Corporate)
Astrid Well­hö­ner, LL.M. Eur. (labor law)
Peter M. Schäff­ler (Taxes)
Dr. Rein­hard Siegert (Anti­trust Law)
Dr. Ruth Schnei­der (Anti­trust Law), all Munich

Boris Dürr’s team regu­larly advi­ses Prim­e­pulse on acqui­si­ti­ons, inclu­ding the take­over of elec­tro­nics manu­fac­tu­rer Katek from the Kath­rein Group in 2018.

News

Frank­furt a. M. — Halder has sold its stake in the Wback Group (Bönen), the leading whole­sale bakery in Germany specia­li­zing in soft rolls, to the Texas-based whole­sale baker and food group C.H. Guen­ther & Son, LLC (San Antonio/Texas).

An esti­ma­ted two million people bite into a WBack soft roll every day — but hardly anyone knows the manu­fac­tu­rer. The company is one of those unknown indus­try giants that operate as a supplier in the back­ground. For exam­ple, WBack is not only the soft roll supplier for the fast food chain Burger King in Germany, but also supplies other system restau­rants and hot dog provi­ders with its burger buns.

Wback was foun­ded in 2003, and in 2013 Halder took over the majo­rity share­hol­ding from foun­der Peter Wendeln as part of a succes­sion solu­tion. The company produ­ces soft rolls in Bönen (North Rhine-West­pha­lia) and Leip­heim (Bava­ria) using state-of-the-art, highly auto­ma­ted equip­ment for renow­ned major custo­mers from the system cate­ring, food retail and food service sectors.

Through a strong expan­sion of produc­tion capa­city, invest­ments in pack­a­ging machi­nes and an inter­me­diate warehouse, Wback has reali­zed high growth with exis­ting and new custo­mers, and sales have doubled since Halder joined the company. With the acqui­si­tion of Wback, C.H. Guen­ther further expands its product range and opens up addi­tio­nal Euro­pean markets.

About Halder
Halder has been active as an equity inves­tor in Germany since 1991 and has provi­ded equity capi­tal for succes­sion and growth to 38 medium-sized compa­nies. Toge­ther with the exits at Klin­gel medi­cal metal, Aqua Vital, KEYMILE and BMB Manif­at­tura Borse, the sale of Wback is the fifth invest­ment sale from the port­fo­lio of the Halder Germany II fund in the past six months. Over­all, Halder has on average signi­fi­cantly more than doubled the value of the invest­ments when they were sold. With the exit at Wback, the return of capi­tal to Halder inves­tors has excee­ded the one billion euro mark.

News

Frank­furt a. Main/ Bonn - Shear­man & Ster­ling advi­sed Ardian Private Debt as lender on the finan­cing of the acqui­si­tion of SER Group by Carlyle Europe Tech­no­logy Part­ners. The sellers retain a substan­tial mino­rity interest.

SER Group, head­quar­te­red in Bonn, Germany, has evol­ved from a pioneer in elec­tro­nic archi­ving to Europe’s number one provi­der of pionee­ring enter­prise content manage­ment (ECM) solu­ti­ons. Foun­ded in 1984, the company is charac­te­ri­zed by its inno­va­tive strength, custo­mi­zed solu­ti­ons and excel­lent custo­mer service.

Ardian, a world-leading private invest­ment house, as a sole lender, has provi­ded a senior finan­cing package to Carlyle Europe Tech­no­logy Part­ners in support of the acqui­si­tion of SER Group in Germany. The finan­cing under­lines the ongo­ing expan­sion of Ardian Private Debt’s direct lending capa­bi­li­ties throug­hout Europe.

Mark Brenke, Mana­ging Direc­tor & Co-Head Ardian Private Debt, said: “As a finan­cing part­ner, we are deligh­ted to be support­ing the SER manage­ment team toge­ther with Carlyle who have a strong track record of inves­t­ing in B2B tech­no­logy busi­nesses. SER is the leading inde­pen­dent ECM soft­ware provi­der in the German m

The Shear­man & Ster­ling team led by Winfried M. Carli included Sven Opper­mann and Marina Kieweg (all Germany-Finance).

About Shear­man & Sterling
Shear­man & Ster­ling is an inter­na­tio­nal law firm with 22 offices in 13 count­ries and appro­xi­m­ately 850 lawy­ers. In Germany, Shear­man & Ster­ling is repre­sen­ted at the Frank­furt office. The firm is one of the inter­na­tio­nal market leaders in advi­sing on complex cross-border tran­sac­tions. World­wide, Shear­man & Ster­ling prima­rily advi­ses inter­na­tio­nal corpo­ra­ti­ons and large natio­nal compa­nies, finan­cial insti­tu­ti­ons, and large mid-sized compa­nies. For more infor­ma­tion, visit www.shearman.com.

News

Duderstadt/ Berlin — Matrazzo GmbH, based in Lower Saxony, Germany, has acqui­red muun, a Berlin-based startup specia­li­zing in custo­mizable mattres­ses that went bank­rupt in 2018. Luther provi­ded legal support for the transaction.

For mattress online retailer muun, it’s all over: last year, the startup foun­ded in 2014 had to file for insol­vency. Mattress manu­fac­tu­rer Matrazzo around CEO Sven Rudolf-Töpfer has now bought the startup with the help of a team from Luther Rechts­an­walts­ge­sell­schaft. In paral­lel, the tran­sac­tion specia­lists nego­tia­ted license agree­ments with the agen­cies respon­si­ble for muun’s corpo­rate design and product range.

The busi­ness opera­ti­ons of muun will conti­nue as an inde­pen­dent brand. Both the product port­fo­lio and the brand presence can thus conti­nue to exist.

Consul­tant Matrazzo: Luther
Corpo­rate / M&A: Dr. Phil­ipp Honisch (lead), Dr. Stefan Galla, Dr. Cédric Müller (all Essen), Denis Ullrich (Leip­zig); Luther, IT / IP: Sebas­tian Laou­to­u­mai, Dr. Maxi­mi­lian Dorn­dorf (both Essen)

News

Aachen — Seed Fonds II Aachen makes a further finan­cing invest­ment in Hemo­vent GmbH. Toge­ther with the exis­ting inves­tors MIG-Invest­ment­fonds, NRW.BANK, KfW Banken­gruppe, First Capi­tal Part­ner and the private inves­tor Prof. Dr. Peter Borges, Aache­ner Betei­li­gungs­ge­sell­schaft is thus provi­ding the neces­sary funds in the mid seven-digit range. With the fresh capi­tal, the startup wants to realize, among other things, the market launch within the scope of a so-called “post-market study”. With this study, the Hemo­vent system “MOBYBOX” will be used on humans for the first time. In paral­lel, the foun­ders are also seeking US FDA approval.

Tech­no­lo­gi­cal advancements
Hemo­vent GmbH has deve­lo­ped one of the world’s smal­lest porta­ble ECMO systems (Extra Corpo­ral Membrane Oxygena­tion, photo), which supports or even comple­tely takes over the natu­ral cardio­pul­mo­nary func­tion in case of cardio­pul­mo­nary insuf­fi­ci­ency or fail­ure. Since the closing of the previous finan­cing round in June 2017, the Aachen-based startup has successfully comple­ted product deve­lo­p­ment and the veri­fi­ca­tion and vali­da­tion phase. Extre­mely posi­tive results have been achie­ved in the in vivo trials and the company expects CE certi­fi­ca­tion later this year.

“Hemo­vent has been deve­lo­ping very posi­tively since Seed Fonds II’s initial commit­ment,” says Markus Krücke­meier, Mana­ging Direc­tor of Seed Fonds Aachen II’s manage­ment company. “So far, the medtech company has been able to reach all mile­sto­nes and even create addi­tio­nal value in some areas. We are very satis­fied — both with the tech­no­lo­gi­cal and the econo­mic progress.”

“We have set our content mile­sto­nes until mid-2020 and are working with a well-coor­di­na­ted manage­ment team to be able to meet all targets on sche­dule,” says Chris­tof Lenz, CEO and co-foun­der of Hemo­vent GmbH. “In order to firmly estab­lish oursel­ves in the market, we have alre­ady been making cont­acts for years with clini­cal experts and users, insti­tu­tio­na­li­zed indus­try experts, and decis­ion-makers from MedTech groups, and we are repre­sen­ted at trade congresses.”

About Seed Fonds II Aachen
Seed Fonds II Aachen was estab­lished in March 2012 as the succes­sor to the fully finan­ced first Seed Fonds Aachen (invest­ment period: 2007–2011) as a follow-up fund from NRW.BANK’s Seed Fonds Initia­tive. In addi­tion to NRW.BANK, Seed Fonds II Aachen is finan­ced by Spar­kasse Aachen and DSA Invest GmbH, which is backed by Aachen-based DSA Daten- und System­tech­nik GmbH. The Seed Fund provi­des young compa­nies in the start-up phase with the neces­sary equity capi­tal and thus stimu­la­tes the deve­lo­p­ment of future-orien­ted tech­no­lo­gies in the Aachen econo­mic region. In 2018, the seed fund was laun­ched for the third time and for the first time also includes the Mönchen­glad­bach region, as the circle of inves­tors has expan­ded to include Spar­kasse Mönchengladbach.

Behind the opera­tio­nal manage­ment of the fund (FM Fonds-Manage­ment für die Region Aachen Betei­li­gungs-GmbH) are the invest­ment experts of the S‑UBG Group. The invest­ment company of the savings banks in the Aachen, Krefeld and Mönchen­glad­bach area looks back on more than 30 years of expe­ri­ence in finan­cing medium-sized compa­nies and tech­no­logy-orien­ted start-ups. www.seedfonds-aachen.de; www.s‑ubg.de.

News

Hamburg — The Hamburg-based manage­ment consul­tancy K&H Busi­ness Part­ner has consis­t­ently repo­si­tio­ned itself for further growth and will conti­nue its successful busi­ness under the name enomyc from 01.02.2019.

Beco­ming a leading consul­ting firm for medium-sized compa­nies that want to grow at full speed in the digi­tal age in terms of perfor­mance manage­ment — this is the goal with which the manage­ment consul­ting firm K&H Busi­ness Part­ner has consis­t­ently deve­lo­ped over the past two years. Now the Hamburg-based company is clearly heading for further growth under the name enomyc.

In the past, enomyc has recei­ved seve­ral awards as Best Advi­sor for consul­ting services in the area of restruc­tu­ring, and has now expan­ded its range of services to include the consul­ting fields of “Digi­tal Trans­for­ma­tion” and “Corpo­rate Perfor­mance” and acqui­red a majo­rity stake in a leading Hamburg-based digi­tal agency at the end of 2018.

“We want to grow and bring SMEs into tomor­row,” says CEO Martin Hammer, explai­ning the new direc­tion of the consul­ting firm K&H Busi­ness Part­ner, which he foun­ded with Uwe Köstens (photo) in 2003. “Set up in this way, we can guide clients even more compre­hen­si­vely on the path to their digi­tal and highly profi­ta­ble future — from stra­tegy to imple­men­ta­tion,” adds Uwe Köstens.

Both mana­ging direc­tors intend to pursue their proven quality and imple­men­ta­tion-orien­ted consul­ting approach with full energy. The ongo­ing successful part­ner­ship between enomyc and SMEs is to be secu­rely contin­ued by a team of seaso­ned consul­tants and excel­lently trai­ned digi­tal natives.

Since its foun­ding in 2003 as a K&H Busi­ness Part­ner, enomyc has successfully supported clients in more than 400 projects and has been named Best Consul­tant in the Restruc­tu­ring cate­gory five times in a row as of 2013. www.enomyc.com

News

Hamburg — A team led by Hamburg-based part­ner Dr. Stefan Duhn­krack has advi­sed Jung­hein­rich AG on the acqui­si­tion of a majo­rity stake in ISI Auto­ma­tion GmbH & Co KG. With its ISIPlus and ISIPro products for the auto­ma­tion of warehouse systems, ISI Auto­ma­tion now beco­mes part of the Jung­hein­rich Group, one of the world’s leading solu­tion provi­ders for intra­lo­gi­stics. This acqui­si­tion comple­ments Jungheinrich’s port­fo­lio in the important area of digi­tiz­ing logi­stics solutions.

ISI Auto­ma­tion GmbH & Co KG is a specia­list for control auto­ma­tion and IT systems. The inter­na­tio­nally active company has its head­quar­ters in Exter­tal and a branch office in Lemgo. The mana­ging direc­tors Frank Marek and Volker Sasse conti­nue to run the company.

Jung­hein­rich AG, Hamburg, is one of the world’s leading solu­tion provi­ders for intra­lo­gi­stics. Foun­ded in 1953, the Group’s port­fo­lio includes mate­rial hand­ling equip­ment, logi­stics systems and services. Jung­hein­rich is repre­sen­ted in 40 count­ries world­wide by its own direct sales compa­nies and in over 80 other count­ries by part­ner compa­nies. Around 18,000 employees work for the Group world­wide. The Jung­hein­rich share is listed on the SDAX.

Advi­sors to Jung­hein­rich AG: Heuking Kühn Lüer Wojtek
Dr. Stefan Duhn­krack (Lead Part­ner, M&A), Hamburg.
Duhnkrack’s team regu­larly advi­ses Jung­hein­rich, most recently on the acqui­si­tion of the MIAS Group.

Inhouse: Attor­ney at Law Dr. Thor­dis Koeppel-Tamms

News

Paris/ Berlin — My Media Group, the market-leading inde­pen­dent consul­ting and media agency group from France, has acqui­red a 51 percent stake in Peak Ace AG. With more than 20 languages in-house, Peak Ace is Germany’s leading inde­pen­dent perfor­mance marke­ting agency.

The invest­ment in Peak Ace is a signi­fi­cant stra­te­gic step in My Media Group’s inter­na­tio­na­liza­tion stra­tegy. It enables the Group to imple­ment high-perfor­mance campaigns and stra­te­gies for its custo­mers on a global scale, thus opening up new markets and scaling inter­na­tio­nally. With its perfor­mance marke­ting exper­tise, Peak Ace comple­ments the group’s five compa­nies, each of which offers its own unique digi­tal marke­ting solutions:

My Media (direct response TV agency), Eggs (crea­tive agency), Search Fore­sight (SEO agency), GeoVista (local media agency), RoiK (direct response TV agency).

Bastian Grimm, CEO and Direc­tor Orga­nic Search at Peak Ace: “We are very exci­ted to now be a part of My Media Group, a team of extre­mely talen­ted entre­pre­neurs we hold in high regard, who have succee­ded in buil­ding an outstan­ding group of compa­nies. We all share a great passion for deli­ve­ring the best possi­ble results for our custo­mers — in line with our own guiding prin­ci­ple: Deli­ve­ring Perfor­mance! It’s great to have a part­ner with the same ambi­ti­ons who appre­cia­tes the value of a progres­sive culture like ours. We look forward to our future toge­ther and are commit­ted to taking Peak Ace to the next level through our partnership.”

Peak Ace AG, foun­ded in 2007, is an inter­na­tio­nally active perfor­mance marke­ting agency head­quar­te­red in Berlin. More than 110 employees from over 20 nati­ons realize campaigns on a native-spea­ker level. With its tech­no­logy-driven approach, Peak Ace AG offers flexi­ble, data-based solu­ti­ons for all rele­vant perfor­mance marke­ting chan­nels from a single source. In this way, the agency enables its clients to use marke­ting spend more effi­ci­ently to operate more profi­ta­bly overall.

Peak Ace’s core busi­ness is perfor­mance marke­ting, which includes paid adver­ti­sing (PPC), orga­nic search (SEO) and content marke­ting, as well as conver­sion rate opti­miza­tion and digi­tal analy­tics. Their inno­va­tive stra­te­gies and campaigns have been awarded the Euro­pean Search Award seve­ral times, inclu­ding for the best SEO campaign. In addi­tion, Peak Ace not only won the “Best Use of Data” cate­gory at the Drum Search Awards, but also recei­ved the pres­ti­gious, cross-cate­gory “Grand Prix” for its excep­tio­nal perfor­mance. Peak Ace’s custo­mers include inter­na­tio­nally renow­ned brands such as Airbnb, SEPHORA, TÜV Süd, Schü­ler­hilfe, the OTTO Group and A&O Hotels and Hostels.

About My Media Group
My Media Group is a media company respon­si­ble for more than 1 billion euros of media budget annu­ally for its more than 500 custo­mers. A leader in the deve­lo­p­ment of media stra­te­gies aimed directly at custo­mer acqui­si­tion, the company is prima­rily active in e‑commerce. It can boast a market share of more than 40% among pure play­ers and refe­ren­ces such as Triv­ago, Grou­pon, Just Eat or Vistaprint.

With 130 employees, My Media Group has succes­si­vely imple­men­ted seve­ral acqui­si­ti­ons, within which Media­top, Geo Vista, Libre et Change, Synodi­ance and Pygma­lion Media have been successfully inte­gra­ted. In just a few years, My Media Group has become a major refe­rence in its market. To acce­le­rate this deve­lo­p­ment in France and inter­na­tio­nally, it is rely­ing on a stra­tegy based on both orga­nic growth oppor­tu­ni­ties and an ambi­tious exter­nal growth strategy.

News

Munich, Germany — Golding Capi­tal Part­ners (Golding), one of Europe’s leading inde­pen­dent asset mana­gers for private equity, private debt and infra­struc­ture, has closed two funds at record levels at the end of 2018. The Golding Private Debt 2016 fund recei­ved capi­tal commit­ments of over €580 million at the close of subscrip­tion, making it Golding’s largest private debt invest­ment program to date. The Golding Infra­struc­ture Co-Invest­ment 2016 fund closed with a final subscrip­tion of €336 million, well above the origi­nal target volume of €300 million.

Golding Private Debt 2016 reaches record volume
With a final subscrip­tion amount of over 580 million euros, the fund volume of Golding Private Debt 2016 is once again signi­fi­cantly higher than that of the prede­ces­sor fund and thus exceeds all previous place­ment results in the important private debt segment. The current invest­ment program was very popu­lar with exis­ting custo­mers, who alone subscri­bed to around 80 percent of the total volume.

Golding Private Debt 2016 provi­des capi­tal to finance corpo­rate acqui­si­ti­ons and growth finan­cing in the Western Euro­pean and North Ameri­can middle market, prima­rily senior secu­red loans. Golding’s addi­tio­nal invest­ment in oppor­tu­ni­stic credit stra­te­gies also stabi­li­zes the fund’s port­fo­lio for uncer­tain or vola­tile market peri­ods. The goal is to build a broadly diver­si­fied port­fo­lio with appro­xi­m­ately 300 under­ly­ing tran­sac­tions. With the subscrip­tion of 15 prima­ries, secon­da­ries and co-invest­ments, this port­fo­lio expan­sion is alre­ady well advan­ced, and so far around 20 percent of the subscri­bed capi­tal has alre­ady been called up from investors.

With this stra­tegy, inves­tors bene­fit from diffe­rent return compon­ents, which may include equity-like compon­ents in addi­tion to an attrac­tive current inte­rest rate. A total of 42 insti­tu­tio­nal inves­tors — inclu­ding pension funds, insu­rance compa­nies, savings banks, coope­ra­tive banks and foun­da­ti­ons — will receive an income distri­bu­tion in the high single-digit percen­tage range on their commit­ted capi­tal alre­ady for 2018.

Mana­ging Direc­tor Huber­tus Theile-Ochel is highly satis­fied: “With the private debt asset class, we are the clear market leader in Germany and conti­nue to enjoy a high level of popu­la­rity among our inves­tors. They appre­ciate the more attrac­tive risk-adjus­ted returns compared to more liquid lever­a­ged loans, bonds and the tradi­tio­nal inte­rest busi­ness. In response to inves­tor demand, we plan to launch the succes­sor fund this year.”

“Golding has been an active inves­tor in the private debt asset class for over 16 years. Our above-average track record clearly demons­tra­tes our proven exper­tise,” affirms company foun­der and mana­ging direc­tor Jeremy Golding (photo) of the inde­pen­dent asset manage­ment company’s exper­tise. “We now manage over €3 billion in this asset class and have inves­ted in a total of 100 prima­ries, secon­da­ries and co-invest­ments from Europe and North America to date.”

Golding Infra­struc­ture Co-Invest­ment 2016 over­sub­scri­bed for final closing
The Golding Infra­struc­ture Co-Invest­ment 2016 invest­ment program provi­des insti­tu­tio­nal inves­tors with direct access to quality-assu­red infra­struc­ture co-invest­ments for the first time. It was successfully closed at €336 million at year-end 2018, excee­ding the origi­nal target of €300 million. The launch under­lines Golding’s posi­tion as one of the leading inde­pen­dent provi­ders of infra­struc­ture invest­ments in Europe and is one of the first Euro­pean provi­ders to offer this form of invest­ment to its investors.

Golding Infra­struc­ture Co-Invest­ment 2016 is desi­gned for inves­tors who aim to quickly commit capi­tal and gain direct expo­sure to infra­struc­ture projects without sacri­fi­cing broad diver­si­fi­ca­tion. “As a large and estab­lished infra­struc­ture fund inves­tor, we have a broad port­fo­lio of assets and a strong network to outstan­ding mana­gers. These are important foun­da­ti­ons for a steady deal flow of attrac­tive co-invest­ment oppor­tu­ni­ties,” said Dr. Matthias Reicher­ter, Part­ner and CIO at Golding.

The port­fo­lio build-up is progres­sing rapidly: of a total of 12 to 14 plan­ned infra­struc­ture co-invest­ments, six have alre­ady been imple­men­ted to date, inclu­ding tran­sac­tions in the trans­port, energy and logi­stics sectors. Almost 40 percent of the subscrip­tion commit­ments have alre­ady been called up from inves­tors, which include in parti­cu­lar insu­rance compa­nies, pension funds and state banks.

“The high demand from insti­tu­tio­nal inves­tors is a clear confir­ma­tion for us that we have filled a real gap with Golding Infra­struc­ture Co-Invest­ment 2016,” confirms Huber­tus Theile-Ochel, Mana­ging Direc­tor of Golding. “Inves­tors looking to target their exis­ting infra­struc­ture port­fo­lio with solid infra­struc­ture assets from Europe and North America will bene­fit from our solution.”

About Golding Capi­tal Partners
Golding Capi­tal Part­ners GmbH is one of the leading inde­pen­dent asset mana­gers for private equity, private debt and infra­struc­ture in Europe. With a team of over 90 employees based in Munich, London, Luxem­bourg, New York and Tokyo, Golding Capi­tal Part­ners supports insti­tu­tio­nal inves­tors in buil­ding their invest­ment stra­tegy and mana­ges assets of more than €7 billion. The more than 160 insti­tu­tio­nal inves­tors include insu­rance compa­nies, pension funds, foun­da­ti­ons, family offices as well as banks, savings banks and coope­ra­tive banks.

News

Schaff­hau­sen (CH) — Record numbers of product appr­ovals, clini­cal breakth­roughs in new thera­pies and further acqui­si­ti­ons — at its most important inves­tor confe­rence at the begin­ning of the year, the biotech indus­try pres­ents itself in strong shape. For a number of BB Biotech port­fo­lio compa­nies, 2019 will be an exci­ting year.

The who’s who of the health­care indus­try met at J.P. Morgan ’s annual inves­tor confe­rence in San Fran­cisco, Cali­for­nia. Scien­tists, mana­gers and inves­tors watched presen­ta­ti­ons and panel discus­sions between Janu­ary 7 and 10 and exch­an­ged ideas at count­less meetings. For BB Biotech’s invest­ment team, the event provi­ded an oppor­tu­nity to meet with the manage­ment of its port­fo­lio compa­nies and also to hold discus­sions with a number of poten­tial new companies.

Acqui­si­ti­ons and licen­sing deals
The number one topic of conver­sa­tion at the start of the confe­rence was the two acqui­si­ti­ons announ­ced at the begin­ning of Janu­ary. In both cases, US phar­maceu­ti­cal compa­nies acted as buyers. Eli Lilly is acqui­ring cancer specia­list Loxo Onco­logy, which recei­ved appr­oval for its first product in Novem­ber 2018, for USD 8 billion. Even more spec­ta­cu­lar is Bris­tol-Myers Squibb ’s acqui­si­tion of BB Biotech ’s long-stan­ding core holding Celgene. The acqui­si­tion price of USD 74 billion repres­ents the largest tran­sac­tion in the history of biotech­no­logy to date and crea­tes one of the world’s largest provi­ders of cancer thera­pies on the sales side.

Even though other phar­maceu­ti­cal compa­nies have indi­ca­ted that they are looking for take­over targets, BB Biotech belie­ves that deals of this magni­tude will remain the excep­tion. The team considers so-called bolt-on acqui­si­ti­ons to be far more likely, with which compa­nies streng­then their port­fo­lio in indi­vi­dual indi­ca­ti­ons via smal­ler acqui­si­ti­ons in the single-digit billion range. “Take­over targets among the biotech heavy­weights include Gilead Scien­ces in onco­logy and gene therapy and Biogen in neuro­logy, in addi­tion to Amgen. The valua­tions of many biotech compa­nies, which remain low despite the recent share price reco­very, will have a support­ive effect on the conclu­sion of such tran­sac­tions,” says Dr. Daniel Koller, Head Invest­ment Team BB Biotech.

The discus­sion about the acqui­si­ti­ons was parti­ally overs­ha­dowed by the nume­rous licen­sing agree­ments announ­ced at the confe­rence. For exam­ple, the subsi­diary Espe­rion Thera­peu­tics signed an agree­ment with Daii­chi Sankyo Europe. Under the terms of the agree­ment, the Japa­nese phar­maceu­ti­cal company will pay USD 300 million in upfront payments and a further USD 900 million in success-based mile­stone payments in return for secu­ring the marke­ting rights to a blood lipid-lowe­ring drug.

Posi­tive newsflow
In terms of price-driving news, Sage Thera­peu­tics provi­ded a high­light of the confe­rence. Its share price shot up 40% after the company announ­ced very good clini­cal data for a product to treat severe post­par­tum depres­sion. This nerve dise­ase is the result of hormo­nal chan­ges after child­birth and affects 400,000 women each year in the U.S. alone. The advan­tage of the subs­tance called SAGE-127 is that it is taken as a tablet over a period of two weeks. In this deli­very form, the drug could also be used for other forms of depres­sion in which Sage is test­ing the drug. If SAGE-127 recei­ves appr­oval, the U.S. biotech company could secure a lucra­tive market niche, as the U.S. FDA is alre­ady deci­ding on March 19 whether to approve Zupressa for the same indi­ca­tion. The disad­van­tage of Zupressa is that this medi­cine must be admi­nis­te­red by infu­sion over a 60-hour period. In any case, the chan­ces are good that Sage will be able to gene­rate annual sales in the billi­ons with these products.

Invest­ment Stra­tegy BB Biotech: Bet on tomorrow’s winners
The latest deve­lo­p­ments in the indus­try confirm BB Biotech’s invest­ment stra­tegy of incre­asingly focu­sing on smal­ler and mid-cap compa­nies that are on the verge of a breakth­rough with new thera­peu­tic approa­ches. Cancer thera­pies remain the largest topic area here, follo­wed by mono­ge­netic rare dise­a­ses and neuro­lo­gi­cal dise­a­ses. The team is very confi­dent that some of the port­fo­lio compa­nies will deli­ver posi­tive price-driving news this year. These include Alexion Pharma with a follow-on product for Soli­ris, a billion-dollar product for the treat­ment of a rare gene­tic disor­der in hema­to­poie­sis. At the same time, manage­ment is working to increase the sales poten­tial of Soli­ris through expan­ded appli­ca­ti­ons in other niche indi­ca­ti­ons. Halo­zyme will submit pivo­tal data for its pancrea­tic cancer treat­ment towards the end of the year. From Vertex Pharma, BB Biotech expects further data from combi­na­tion studies in cystic fibrosis.

Inter­cept and Gilead Scien­ces will present pivo­tal clini­cal data from their candi­da­tes for the treat­ment of non-alco­ho­lic fatty liver (NASH) in H1 2019. These medi­ca­ti­ons could be used to treat the early and late forms of the dise­ase. In the USA alone, up to 2 million people are affec­ted by liver cirrho­sis as a result of fatty liver and at least the same number by liver fibro­sis, which in most cases can only be trea­ted by liver trans­plan­ta­tion. The actual sales poten­tial for this dise­ase, which until now has been virtually untreata­ble, will only become appa­rent once the first products have been appro­ved. The main issue here is to deter­mine how long and inten­sive the medi­ca­tion of NASH in its early forms will be in redu­cing the fat content in the liver and impro­ving the blood count, and to what extent the new thera­pies will have a cura­tive effect in the late stages of the disease.

As in other dise­ase areas, BB Biotech posi­tio­ned itself here at an early stage, as soon as the medi­cal and commer­cial success of the new thera­peu­tic approa­ches was convin­cing. The above-average perfor­mance of BB Biotech’s shares compared to the indus­try under­pins this invest­ment approach. www.bbbiotech.com

News

Frank­furt a.M. - Gleiss Lutz part­ners streng­then M&A prac­tice with Dr. Andreas Löhde­fink (photo), previously M&A part­ner at Shear­man & Ster­ling, as part­ner. The exact date of the change has not yet been deter­mi­ned. With the addi­tion of Andreas Löhde­fink, Gleiss Lutz is expan­ding its Finan­cial Insti­tu­ti­ons prac­tice with Dr. Rainer Loges and Dr. Jan Bals­sen, as well as its gene­ral M&A team, follo­wing the part­ner appoint­ment of Dr. Tobias Harzenet­ter (focus: insurance).

Andreas Löhde­fink joined Shear­man & Ster­ling in Frank­furt in 2010, where he became a part­ner in Janu­ary 2014. He has a focus in M&A for finan­cial insti­tu­ti­ons and insu­rance compa­nies and is co-head of Shearman’s global Insu­rance Group. He also advi­ses on gene­ral M&A and on corpo­rate and capi­tal markets law issues. IFLR 1000 names Andreas Löhde­fink as a ‘Highly Regarded Prac­ti­tio­ner’ for Corporate/M&A, JUVE recom­mends him as a lawyer for M&A.

Andreas Löhde­fink on his move: “Of course, the decis­ion is not easy for me, as many profes­sio­nal and perso­nal connec­tions have been made at Shear­man over the years. But Gleiss Lutz’s extra­or­di­nary repu­ta­tion and stra­te­gic focus open up oppor­tu­ni­ties for me to deve­lop my own prac­tice in M&A and in
Finan­cial Insti­tu­ti­ons area to deve­lop further in a great environment.”

Dr. Alex­an­der Schwarz, Co-Mana­ging Part­ner of Gleiss Lutz, commen­ted: “We are very plea­sed to have gained a renow­ned M&A part­ner in Andreas Löhde­fink. He is an excel­lent fit for our team and will signi­fi­cantly advance our M&A prac­tice with his focus on finan­cial insti­tu­ti­ons, a stra­te­gi­cally promi­sing area.”

News

Bad Homburg/Engelskirchen/Frankfurt — Alan­tra, a global invest­ment banking and asset manage­ment firm focu­sed on the mid-market segment, advi­sed HQ Equita, the direct invest­ment arm of HQ Capi­tal, on the refi­nan­cing of its port­fo­lio company The Pack­a­ging Group (“TPG”). TPG is a global leader in the design and manu­fac­ture of premium pack­a­ging machi­nery for the food, pet food and chemi­cal indus­tries. — Alan­tra struc­tu­red and arran­ged new credit faci­li­ties in a compe­ti­tive process to repay share­hol­der loans from HQ Equita and to refi­nance exis­ting debt. In addi­tion, the company recei­ved new acqui­si­tion and CapEx lines for orga­nic and exter­nal growth.

TPG deve­lops and manu­fac­tures pack­a­ging machi­nes for filling dry, free-flowing bulk mate­ri­als into various types of bags made of paper or plas­tic lami­nate. The machi­nes provide pack­a­ging solu­ti­ons for flour, sugar, baking mixes, confec­tion­ery, pet food, and various chemi­cal products, among others. The service and spare parts busi­ness also accounts for around a quar­ter of TPG’s sales. The company, with 210 employees at four inter­na­tio­nal produc­tion and sales loca­ti­ons, was crea­ted in 2018 by merging FAWEMA and HDG (form­erly: Steindl Group) under HQ Equita.

The finan­cing volume provi­ded by a consor­tium consis­ting of Commerz­bank and Olden­bur­gi­sche Landes­bank (OLB) supports TPG in expan­ding its tech­ni­cal compe­ten­cies and geogra­phi­cal reach through targe­ted acqui­si­ti­ons in order to further expand its market posi­tion as a globally active plat­form in the pack­a­ging machi­nery market. The streng­the­ned debt capi­tal base also enables TPG to expand a produc­tion site and build a third state-of-the-art “green­field” produc­tion faci­lity. In addi­tion, it is inten­ded to acce­le­rate invest­ments in sales, as well as rese­arch and deve­lo­p­ment, and to further insti­tu­tio­na­lize the organization.

Florian Wiem­ken, who is mana­ging HQ Equita’s invol­vement with TPG, said: “This finan­cing package is very well struc­tu­red and allows TPG to grow sustain­ably. Germany is a leader in the highly frag­men­ted pack­a­ging machi­nery market and the acqui­si­tion line will allow TPG to acce­le­rate its orga­nic and exter­nal growth in this envi­ron­ment. Alan­tra led a very compe­ti­tive process with the finan­cing banks and did an excel­lent job on this transaction.”

Robert von Fincken­stein, Mana­ging Part­ner and Head of Debt Advi­sory in Alantra’s Frank­furt office, added: “The refi­nan­cing of TPG is alre­ady the fifth tran­sac­tion for HQ Equita in the past four years and our twelfth debt advi­sory mandate in the past twelve months. It also conti­nues the string of successful tran­sac­tions Alan­tra has comple­ted for its clients in the pack­a­ging indus­try, inclu­ding HQ Equita’s sale of Rovema to Haniel in 2017 and IMA’s acqui­si­tion of Odewald’s Oystar dairy busi­ness in 2015.”

About Alan­tra
Alan­tra is a global invest­ment banking and asset manage­ment firm focu­sed on the mid-market segment with offices in Europe, the US, Asia and Latin America. With over 330 experts, the Invest­ment Banking unit provi­des inde­pen­dent advice on M&A, corpo­rate finance, loan port­fo­lios and capi­tal market tran­sac­tions. The Asset Manage­ment unit mana­ges assets of around 4.5 billion euros in the asset clas­ses private equity, active funds, private debt, real estate and wealth manage­ment. For more infor­ma­tion, please visit: www.alantra.com.

About HQ Capital
HQ Capi­tal is one of the leading inde­pen­dent invest­ment mana­gers for alter­na­tive capi­tal invest­ments. Since 1989, HQ Capi­tal has inves­ted globally in private equity and U.S. real estate for insti­tu­ti­ons and fami­lies. Over 145 employees manage and invest appro­xi­m­ately $12 billion (as of Septem­ber 30, 2018) from 10 loca­ti­ons in North America, Europe and Asia.
HQ Equita is the invest­ment busi­ness of HQ Capi­tal. For more than three deca­des, the focus of HQ Equita has been on invest­ments and share­hol­dings in medium-sized compa­nies in German-spea­king count­ries. From Bad Homburg, around 15 specia­lists support medium-sized compa­nies in their growth and trans­for­ma­tion. Since 1992, HQ Equita has raised around one billion euros in capi­tal and inves­ted in over 30 companies.

News

Munich, Hamburg — Equistone’s port­fo­lio company PIA (Perfor­mance Inter­ac­tive Alli­ance) is acqui­ring UDG United Digi­tal Group, a service provi­der specia­li­zing in digi­tal user expe­ri­ence (UX) and tech­no­logy. With this acqui­si­tion, PIA is conti­nuing its stra­tegy of brin­ging toge­ther market-leading compa­nies from the core areas of digi­tal marke­ting in their respec­tive sub-disci­pli­nes in order to offer inte­gra­ted custo­mer solu­ti­ons from a single source. The seller is EQT and the tran­sac­tion is expec­ted to close by the end of Febru­ary 2019. The parties have agreed not to disc­lose details of the tran­sac­tion. — The acqui­si­tion is still subject to appr­oval by the rele­vant anti­trust autho­ri­ties. Equis­tone first inves­ted in PIA Group in 2014 and has since supported the manage­ment seve­ral times in the acqui­si­tion of further digi­tal agencies.

UDG was foun­ded in 2011 and has subse­quently deve­lo­ped into one of the leading digi­tal agen­cies in the field of user expe­ri­ence (UX), today combi­ning exper­tise in concept & design, digi­tal archi­tec­ture and imple­men­ta­tion of projects in this area. The company with a Annual sales of approx. EUR 40 million employs around 400 employees. Services range from stra­te­gic marke­ting consul­ting to digi­tal design and imple­men­ta­tion. UDG serves well-known custo­mers such as Porsche, Beiers­dorf, Volks­wa­gen, Stihl, KSB and Puma.

Chris­tian Tiede­mann, CEO of the PIA Group, explains: “With the acqui­si­tion of UDG, we can expand our range of exper­tise to include top-class specia­lists and our custo­mer base to include global blue-chip custo­mers. PIA and UDG essen­ti­ally origi­na­ted from the same idea in terms of content, but have posi­tio­ned them­sel­ves in the market with diffe­rent imple­men­ta­tion. We are very plea­sed to welcome our new colle­agues and now proudly present our clients with a service port­fo­lio that is decisi­vely streng­the­ned by top-class UX and excel­lent tech­no­logy know-how. By combi­ning stra­tegy, crea­ti­vity and tech­no­logy into Data Driven Marke­ting, we create the decisive added value for our customers.”

Dr. Marc Arens, Part­ner at Equis­tone, says: “UDG is an ideal addi­tion for PIA Group, as it adds an important service to the company’s range of services in the growing market for digi­tal user expe­ri­ence in Germany. This will also bene­fit PIA in future tenders from major clients, as the digi­tal company now offers all sub-disci­pli­nes for inno­va­tive and inte­gra­ted digi­tal custo­mer acqui­si­tion and reten­tion from a single source.”

The three long-time UDG mana­gers Markus Lucht, Mathias Rein­hardt and Ulrich Barthol­mös will conti­nue to jointly lead the opera­tio­nal busi­ness of UDG as Mana­ging Part­ners and report directly to PIA CEO Chris­tian Tiede­mann. Dr. Marc Arens and Lean­der Heyken are respon­si­ble for the tran­sac­tion on the part of Equis­tone. The mid-market inves­tor was advi­sed on the tran­sac­tion by KPMG (Finan­cial & Tax), Renzen­brink & Part­ner (Legal M&A), Ashurst (Legal Finan­cing) and GCA Altium (Finan­cing).

About PIA Group
PIA Group is one of the leading digi­tal service provi­ders in Germany. The holding company was foun­ded in 2014 with the parti­ci­pa­tion of Equis­tone Part­ners Europe and unites ten successful compa­nies under one umbrella brand: Appico, blue­Sum­mit, DELASOCIAL, DYMATRIX, econda, Feed Dyna­mix, .muse49, Perfor­mance Media, SEVEN SQUARED and TAB.

PIA combi­nes stra­tegy, crea­ti­vity and tech­no­logy into Data Driven Marke­ting. As an enabler, PIA Group supports custo­mers with analy­ti­cal and tech­no­lo­gi­cal know-how from a single source in the digi­tal trans­for­ma­tion of their busi­ness models and contri­bu­tes to new busi­ness and custo­mer acqui­si­tion. PIA Group sustain­ably impro­ves the effi­ci­ency and effec­ti­ve­ness of all digi­tal sales and marke­ting acti­vi­ties of B2C and B2B custo­mers and opti­mi­zes custo­mer value and custo­mer relationships.

Head­quar­te­red in Hamburg and with offices in Berlin, Munich, Stutt­gart, Karls­ruhe, Frankfurt/Main, Düssel­dorf, Belgrade, Tel Aviv, Seoul, Delhi and San Fran­cisco, the compa­nies of the PIA Group with more than 750 experts serve renow­ned clients such as Alli­anz, BMW, Bosch, Deich­mann, Deut­sche Bahn, Deut­sche Bank, Luft­hansa, Metro, Media­Markt, Miele, Mobile.de, Otto, Spotify, Tchibo, Tele­kom, TUI and Unile­ver. www.pia.me

About UDG United Digi­tal Group
Born as a digi­tal agency from eleven leading specia­lists in 2011, UDG United Digi­tal Group has grown into a leading agency for topics rela­ted to digi­tal trans­for­ma­tion in a dyna­mic, custo­mer-centric and tech­noid market environment.

Our play­ing field is digi­tiza­tion. Our DNA is digi­tal. Our thin­king is driven by crea­ti­vity. With this holi­stic exper­tise and specia­liza­tion in the areas of Tech­no­logy Stra­tegy, IT Deve­lo­p­ment & Digi­tal Solu­ti­ons, User Expe­ri­ence, Campaigns, Content, Crea­tive & Design and Consul­ting, as well as in a stra­te­gic part­ner­ship Digi­tal Perfor­mance & Solu­ti­ons, we combine all important topics for our customers.

UDG United Digi­tal Group deve­lops a fully inte­gra­ted digi­tal custo­mer expe­ri­ence for inter­na­tio­nal corpo­ra­ti­ons as well as for market-leading, medium-sized compa­nies. www.udg.de

About Equis­tone Part­ners Europe
Equis­tone Part­ners Europe is one of Europe’s leading equity inves­tors with a team of more than 35 invest­ment specia­lists in six offices in Germany, Switz­er­land, France and the UK. Equis­tone prima­rily invests in estab­lished medium-sized compa­nies with a good market posi­tion, above-average growth poten­tial and an enter­prise value of between EUR 50 and 500 million. Since its foun­ding, equity has been inves­ted in more than 140 tran­sac­tions, mainly mid-market buy-outs. The port­fo­lio curr­ently compri­ses over 40 compa­nies across Europe, inclu­ding around 20 active invest­ments in Germany, Switz­er­land and the Nether­lands. Equis­tone is curr­ently inves­t­ing from its sixth fund, which closed in March 2018 with €2.8 billion at hard cap.

News

Munich, Janu­ary 21, 2019 — Equis­tone Part­ners Europe (“Equis­tone”), one of the leading private equity inves­tors in Europe, has made targe­ted enhance­ments to its invest­ment teams in the DACH region. As of Janu­ary 1, 2019, three employees were promo­ted to invest­ment mana­gers in Munich and Zurich. Phil­ipp Gauß joins the Munich office as an asso­ciate. Further promo­ti­ons were also made at the turn of the year within the invest­ment teams in London and Paris, and Andi Tomkin­son was appoin­ted Part­ner in Manchester.

“We are plea­sed to be able to streng­then our invest­ment teams in Munich and Zurich in this way,” says Dirk Sche­kerka (photo), Senior Part­ner and Coun­try Head DACH at Equis­tone. “On the one hand, the deve­lo­p­ment reflects our strong perfor­mance as a team. On the other hand, it proves our commit­ment that outstan­ding perfor­mance at Equis­tone is also rewarded with corre­spon­ding career steps.”

The new invest­ment mana­gers in Munich are Tanja Berg and Moritz Treude. Tanja Berg joined Equis­tone in 2016 and has deep know­ledge in corpo­rate finance, M&A and control­ling, both on the advi­sory and corpo­rate side. At Equis­tone, she mana­ges the port­fo­lio compa­nies Bien-Zenker and Hanse Haus, GALA Kerzen and Vivo­nio Furni­ture Group. Moritz Treude, who has been with the private equity inves­tor since Octo­ber 2017, previously worked as a manage­ment consul­tant and also in a manage­ment capa­city, prima­rily in the indus­trial goods and retail sectors. He accom­pa­nies the invest­ment at BOAL Group. New to the Equis­tone team in Munich is Phil­ipp Gauss. Prior to joining, he was a project mana­ger for Stern Stewart, a stra­tegy consul­ting firm. There he advi­sed clients from the indus­trial goods, energy and media sectors on tran­sac­tions and restruc­tu­rings. Phil­ipp Gauss holds a Master’s degree in Manage­ment from the Univer­sity of Mann­heim and a Bachelor’s degree in Busi­ness Admi­nis­tra­tion from the EBS Univer­sity of Econo­mics and Law in Oestrich-Winkel.

In Zurich, Roman E. Hegglin has been appoin­ted Invest­ment Mana­ger. There, he is respon­si­ble for project manage­ment and the execu­tion of private equity tran­sac­tions. Prior to joining Equis­tone in May 2016, Hegglin worked as an analyst and asso­ciate in M&A and capi­tal markets in the banking and finan­cial sectors.

“Equis­tone prides itself on provi­ding its employees with a highly profes­sio­nal envi­ron­ment in which they can conti­nuously deve­lop and expand their know­ledge and skills,” says Dirk Sche­kerka. “This is a strong signal, both to the manage­ment teams of our port­fo­lio compa­nies and to our investors.”

As of Janu­ary 1, there were also three promo­ti­ons in the UK and one in France. In Manches­ter, Andi Tomkin­son, who joined Equis­tone in 2012 as an invest­ment direc­tor, is now a part­ner. He will be respon­si­ble for invest­ments and manage­ment of port­fo­lio compa­nies in the North of England. He will conti­nue to serve as a non-execu­tive direc­tor on the boards of Equistone’s port­fo­lio compa­nies. Richard Briault and Tris­tan Manuel were appoin­ted Invest­ment Direc­tors in London, as was Florent Rostaing in the Paris office.

About Equis­tone Part­ners Europe
Equis­tone Part­ners Europe is one of Europe’s leading equity inves­tors with a team of more than 35 invest­ment specia­lists in six offices in Germany, Switz­er­land, France and the UK. Equis­tone prima­rily invests in estab­lished medium-sized compa­nies with a good market posi­tion, above-average growth poten­tial and an enter­prise value of between EUR 50 and 500 million. Since its foun­ding, equity has been inves­ted in more than 140 tran­sac­tions, mainly mid-market buy-outs. The port­fo­lio curr­ently compri­ses over 40 compa­nies across Europe, inclu­ding around 20 active holdings in Germany, Switz­er­land and the Nether­lands. Equis­tone is curr­ently inves­t­ing from its sixth fund, which closed in March 2018 with €2.8 billion at the hard cap.

News

Munich, London, Paris — Euro­pean private equity firm Silver­fleet Capi­tal has acqui­red a majo­rity stake in STAXS Conta­mi­na­tion Control Experts (Staxs NV). The company is one of the leading suppli­ers of clean­room access­ories in the Bene­lux count­ries. The Euro­pean Invest­ment Fund (EIF) has provi­ded addi­tio­nal capi­tal for the tran­sac­tion, the purchase price of which has not been disc­lo­sed. It was imple­men­ted by the invest­ment team at Silver­fleet Capi­tal, which specia­li­zes in smal­ler mid-market companies.

Foun­ded in 1995, STAXS is head­quar­te­red in Heeren­veen, the Nether­lands, and also has two loca­ti­ons in Belgium, Niel and Aart­s­el­aar; the company employs a total of around 80 people. As a value-added distri­bu­tor, STAXS sells high-quality disin­fec­tants and clea­ning agents, corre­spon­ding wipes and tools, as well as gloves and disposable clot­hing used for hygiene in clean­rooms in the life scien­ces and other sectors. STAXS also deve­lops and markets its own products under the DOTCH brand. A laun­dry service for clean­room clot­hing is also offe­red. The company has built up an excel­lent repu­ta­tion as an expert in conta­mi­na­tion protec­tion on the basis of high quality and relia­bi­lity and serves a loyal, also inter­na­tio­nally incre­asing regu­lar clientele.

Toge­ther with Silver­fleet Capi­tal, STAXS now intends to conti­nue its strong growth — the focus will be on expan­ding the product port­fo­lio and custo­mer base, further streng­thening the orga­niza­tion and expan­ding geogra­phi­cally. This includes a capa­city expan­sion at the Heeren­veen site due to the increased demand for DOTCH products. To the part­ner­ship, Silver­fleet Capi­tal brings exten­sive expe­ri­ence in deve­lo­ping compa­nies in the health­care market, gained during the team’s successful invest­ments in a phar­maceu­ti­cal contract manu­fac­tu­rer and a steri­liza­tion specia­list, among others.

“STAXS is a super­bly posi­tio­ned company whose jour­ney we’ve been follo­wing for a long time,” said Alex Breb­bia (pictu­red), a part­ner at Silver­fleet Capi­tal and co-head of its small middle market invest­ment team. “We look forward to now working closely with CEO Johan-Detlef Dubbel­boer, the manage­ment team and employees to unlock further growth potential.”

Erik Fuchs, co-head of invest­ment acti­vi­ties in the Bene­lux, added: “The invest­ment in STAXS demons­tra­tes Silver­fleet Capital’s contin­ued commit­ment to the region. We want to actively support another local market leader in its internationalization.”

Johan-Detlef Dubbel­boer, CEO of STAXS since 2007, states, “I am looking forward to the part­ner­ship with Silver­fleet Capi­tal and the next phase of growth. The company has an impres­sive track record in further deve­lo­ping and inter­na­tio­na­li­zing Euro­pean mid-sized compa­nies and exten­sive expe­ri­ence in the health­care market.”

The Silver­fleet Capi­tal team hand­ling the tran­sac­tion includes invest­ment experts Alex Breb­bia, Erik Fuchs and Peter Kise­nyi. Silver­fleet Capi­tal was advi­sed by Deloitte (Finan­cial & Tax), CIL (Commer­cial), Stek (Legal, Corpo­rate & Banking) and AJ Gallag­her (Insu­rance).

About Silver­fleet Capital
Silver­fleet Capi­tal has been active as a private equity inves­tor in the Euro­pean mid-market for more than 30 years and curr­ently mana­ges around €1.2 billion with its 30-strong invest­ment team in Munich, London, Paris, Stock­holm and Amsterdam.

Eight invest­ments have alre­ady been made from the second inde­pen­dent fund closed in 2015 with a volume of 870 million euros: The Masai Clot­hing Company, a women’s fashion whole­sa­ler and retailer head­quar­te­red in Denmark; Coven­tya, a French deve­lo­per of specialty chemi­cals; Sigma Compon­ents, a U.K. manu­fac­tu­rer of precis­ion compon­ents for civil avia­tion; Life­time Trai­ning, a U.K. provi­der of trai­ning programs; Pumpen­fa­brik Wangen, a manu­fac­tu­rer of specialty pumps based in Germany; Riviera Travel, a British opera­tor of escor­ted group tours and crui­ses; 7days, a West­pha­lian supplier of medi­cal work­wear; and Prefere Resins, a leading phen­o­lic and amino resin manu­fac­tu­rer in Europe.

Silver­fleet achie­ves value growth through its “buy to build” invest­ment stra­tegy. As part of this stra­tegy, Silver­fleet is acce­le­ra­ting the growth of its subsi­dia­ries by inves­t­ing in new products, produc­tion capa­city and employees, instal­ling successful retail formats or making follow-up acqui­si­ti­ons. Since 2004, Silver­fleet Capi­tal has inves­ted €1.9 billion in 28 companies.

Silver­fleet specia­li­zes in four key indus­tries: Busi­ness and Finan­cial Services, Health­care, Manu­fac­tu­ring, and Retail and Consu­mer Goods. Since 2004, the private equity inves­tor has inves­ted 33 percent of its assets in compa­nies head­quar­te­red in the DACH region, 31 percent in the UK and Ireland, 19 percent in Scan­di­na­via and 17 percent mainly in France and the Bene­lux count­ries (1).

Silver­fleet Capi­tal has a solid invest­ment track record. Most recently, Silver­fleet sold Ipes, a leading provi­der of outsour­cing services to Euro­pean private equity firms (invest­ment multi­ple 3.8x); CCC, one of the leading BPO services provi­ders in Europe, as well as Cimbria, a Danish manu­fac­tu­rer of agri­cul­tu­ral equip­ment (2); Kalle, a German manu­fac­tu­rer of arti­fi­cial sausage pellets (invest­ment multi­ple 3.5x); OFFICE, a UK foot­wear retailer (invest­ment multi­ple 3.4x); and Aesica, a leading phar­maceu­ti­cal CDMO company (invest­ment multi­ple 3.3x).

(1) Includes an invest­ment head­quar­te­red in the USA and sourcing in Belgium. (2) Mention of invest­ment multi­ple not possi­ble for legal reasons

News

Berlin/Wied — MEDIAN, since 2011 a port­fo­lio company of the invest­ment company Water­land Private Equity Invest­ments and the largest private opera­tor of reha­bi­li­ta­tion clinics in Germany, takes over Klini­ken Wied GmbH & Co KG. With two homes in the region between Bonn and Koblenz (Wied and Stei­mel), the company has specia­li­zed in inpa­ti­ent reha­bi­li­ta­tion in the field of addic­tion disor­ders since 1974, a core area also of MEDIAN. With 166 employees, the Wied clinics care for more than 210 plan­ned beds. The focus is on inpa­ti­ent and outpa­ti­ent treat­ment of alco­hol, medi­ca­tion and drug addic­tion, co-treat­ment of soma­tic and psycho­so­ma­tic illnesses as well as non-subs­tance-rela­ted addic­tions such as eating disor­ders and gambling addiction.

Dr. Cars­ten Rahlfs, Mana­ging Part­ner of Water­land, says: “The two homes are a respec­ted insti­tu­tion. With their focus areas and high quality of care, they are an ideal fit for MEDIAN. At the same time, we can once again increase our regio­nal presence in Rhine­land-Pala­ti­nate. We are consis­t­ently conti­nuing our buy-and-build stra­tegy, which has made MEDIAN the largest private rehab clinic operator.”

With Waterland’s support, the MEDIAN Group has grown in recent years, in what is now 19 tran­sac­tions, into a company that is one of the five largest private hospi­tal groups in Germany and is inves­t­ing heavily in buil­dings, tech­ni­cal equip­ment, digi­tiza­tion and new tools to better measure thera­peu­tic success. With Waterland’s tran­sac­tional exper­tise, the Group conti­nues to grow in a frag­men­ted market, offe­ring pati­ents and payers a distinc­tive profile and high quality stan­dards. Toge­ther with the two new faci­li­ties, the Group now compri­ses 120 faci­li­ties employ­ing 15,000 staff and trea­ting more than 230,000 inpa­ti­ents annu­ally in more than 18,000 beds. The health­care company includes reha­bi­li­ta­tion clinics as well as psych­ia­tric acute care hospi­tals, therapy centers, outpa­ti­ent clinics and reinte­gra­tion faci­li­ties in 14 states. The company thus offers nati­on­wide coverage of so-called after­care and parti­ci­pa­tion services.

About Water­land
Water­land is an inde­pen­dent private equity invest­ment firm that helps compa­nies realize their growth plans. With substan­tial finan­cial support and indus­try exper­tise, Water­land enables its port­fo­lio compa­nies to achieve acce­le­ra­ted growth both orga­ni­cally and through acqui­si­ti­ons. Water­land has offices in the Nether­lands (Bussum), Belgium (Antwerp), Germany (Munich, Hamburg), Poland (Warsaw), the UK (Manches­ter), Denmark (Copen­ha­gen) and Switz­er­land (Zurich). Curr­ently, 6 billion euros in equity funds are managed.

Water­land has consis­t­ently outper­for­med its invest­ments since its foun­ding in 1999 and has regu­larly ranked among the top three leading private equity firms world­wide in past HEC/Dow Jones Private Equity Perfor­mance Rankings. In addi­tion, Water­land has also been among the top 3 most consis­tent buyout fund mana­gers globally in the Preqin Consis­tent Perfor­mers in Global Private Equity & Venture Capi­tal Report in recent years.

Water­land is listed as a fund mana­ger in the direc­tory main­tai­ned by the Dutch regu­la­tor AFM (Auto­ri­teit Finan­ciële Markten).

News

In connec­tion with the acqui­si­tion of ICP Tran­sac­tion Solu­ti­ons GmbH by Operando Part­ners and other inves­tors, HF Private Debt Fonds, SCSp provi­ded debt finan­cing for the further expan­sion of the ICP Group. The finan­cing volume was not disclosed.

The ICP Group, with loca­ti­ons in Germany, the Nether­lands, Poland and the Czech Repu­blic, opera­tes as one of the leading distri­bu­tors and tech­ni­cal service provi­ders in the dyna­mic market of prepaid solu­ti­ons, which includes not only the clas­sic area of mobile prepaid cards. Rather, prepaid today opens the door for a variety of content provi­ders to distri­bute their products through offline sales chan­nels such as gas stati­ons, grocery stores, and other retail­ers. ICP aims to achieve further growth by broa­de­ning its product and custo­mer base.

HF Debt GmbH acts as exclu­sive advi­sor to the Luxem­bourg-based HF Private Debt fund, SCSp. The fund specia­li­zes in provi­ding private debt finan­cing for small and medium-sized compa­nies (EBITDA between EUR 2–10 million) and provi­des support in the case of growth finan­cing, succes­sion solu­ti­ons and buy-outs by private equity inves­tors. The geogra­phi­cal focus is on German, Western and Nort­hern Euro­pean compa­nies with a history of seve­ral years.

Advi­sors to HF Debt GmbH: Heuking Kühn Lüer Wojtek
Thomas K. W. Schrell, LL.M. (Lead Part­ner, Banking & Finance), Frankfurt
Anja Harms (Banking & Finance), Frankfurt

News

Munich — Mecu­ris GmbH, a Munich-based medi­cal tech­no­logy start-up focu­sing on the digi­tiza­tion of pros­the­ses and ortho­tics, successfully closes a Series A finan­cing round of €3.6 million. In addi­tion to the exis­ting seed inves­tors Bayern Kapi­taland High-Tech Grün­der­fonds (HTGF), Vesa­lius Bioca­pi­tal, Mulcan Inter­na­tio­nal Invest­ments and one of the top five hospi­tal chains in Germany are newly on board.

Every pati­ent is unique. The requi­re­ments that ortho­pe­dic tech­ni­ci­ans have to meet in their care are ther­e­fore just as complex — with constantly incre­asing cost and time pres­sure. For this reason, off-the-shelf ortho­ses or pros­the­ses have often been used up to now. They serve their purpose, but do not fit ideally.

This is where Mecu­ris inter­venes in the supply process. The young company aims to signi­fi­cantly improve the quality of life for pati­ents while saving ortho­pe­dic tech­ni­ci­ans time and money. The aim is to work toge­ther with ortho­pe­dic tech­ni­ci­ans and wearers to design pati­ent-speci­fic ortho­ses and pros­the­ses that are as indi­vi­dual in their func­tion­a­lity as they are in their design, color and struc­ture. To this end, Mecu­ris provi­des ortho­tists with an easy-to-use online plat­form, the Mecu­ris Solu­tion Plat­form, with which they can tailor ortho­ses and pros­the­ses. These are manu­fac­tu­red using 3D prin­ting and deli­vered within a few days. In addi­tion, the start-up offers services for medi­cal supply stores to trans­fer ortho­pe­dic products into a digi­tal process chain, bring them to market quickly and make them scalable in sales.

The approach of using and mone­tiz­ing digi­tiza­tion for perso­na­li­zed ortho­tics and prosthe­tics has convin­ced the new and exis­ting inves­tors. The foun­ding team was able to attract three new inves­tors for the Series A finan­cing: Vesa­lius Bioca­pi­tal III SICAR, MII Mulcan Inter­na­tio­nal Invest­ments GmbH and one of the five largest hospi­tal chains in Germany and Europe. The latter aims to open up digi­tiza­tion for its part­ners — the medi­cal supply stores. In addi­tion, the seed inves­tors Bayern Kapi­tal GmbH and High-Tech Grün­der­fonds Manage­ment GmbH (HTGF) have contin­ued to support the company’s goals.

Mecu­ris will use the proceeds from the finan­cing round to deve­lop the Euro­pean market and streng­then sales. In addi­tion, the start-up will conti­nue to deve­lop new digi­tal solu­ti­ons to comple­ment its own port­fo­lio and fill market gaps that other play­ers have not yet been able to serve.

About Mecu­ris GmbH
Mecu­ris works closely with certi­fied ortho­tists (OTs) to bring ortho­tics & prosthe­tics into the digi­tal age. By bund­ling 3D tech­no­lo­gies in an intui­tive Mecu­ris Solu­tion Plat­form, Mecu­ris OTs are able to design custo­mi­zed ortho­ses & pros­the­ses in a cost- and time-saving way, making their work much easier. OTs are enab­led on the plat­form to custo­mize product ideas for speci­fic pati­ents without CAD design skills and work with the wearer to realize design wishes. This impro­ves the quality of life of the users enorm­ously: they have the chance to quickly become active again and live their indi­vi­dua­lity. Thanks to CE marking and ISO certi­fi­ca­tion, Mecu­ris products meet the highest safety stan­dards and are reim­bur­sed by all health insu­rance compa­nies in Germany.

About Bayern Kapital
Bayern Kapi­tal GmbH, based in Lands­hut, was foun­ded in 1995 as a wholly owned subsi­diary of LfA Förder­bank Bayern on the initia­tive of the Bava­rian state govern­ment. As the venture capi­tal company of the Free State of Bava­ria, Bayern Kapi­tal provi­des equity capi­tal to the foun­ders of inno­va­tive high-tech compa­nies and young, inno­va­tive tech­no­logy compa­nies in Bava­ria. Bayern Kapi­tal curr­ently mana­ges eleven invest­ment funds with an invest­ment volume of around 325 million euros. To date, Bayern Kapi­tal has inves­ted around 290 million euros of venture capi­tal in 265 inno­va­tive tech­no­logy-orien­ted compa­nies from a wide range of sectors, inclu­ding life scien­ces, soft­ware & IT, mate­ri­als & new mate­ri­als, nano­tech­no­logy and envi­ron­men­tal tech­no­logy. As a result, more than 5,000 jobs have been perma­nently crea­ted in Bava­ria in sustainable compa­nies. www.bayernkapital.de

About High-Tech Gründerfonds
High-Tech Grün­der­fonds (HTGF) is a seed inves­tor that finan­ces tech­no­logy-driven start-ups with high poten­tial. With a total invest­ment volume of 892.5 million euros across three funds and an inter­na­tio­nal part­ner network, HTGF has alre­ady supported 500 start-ups since 2005. Driven by their exper­tise, entre­pre­neu­rial spirit and passion, a team of expe­ri­en­ced invest­ment mana­gers and start-up experts supports the deve­lo­p­ment of young compa­nies. HTGF focu­ses on high-tech start-ups in various indus­tries, inclu­ding soft­ware, hard­ware and life sciences/chemicals.

HTGF can point to success stories such as Mister Spex, Rigon­tec, 6Wunderkinder, Next Kraft­werke and Cumu­lo­city, as well as Juniqe, an online store for art lovers. To date, exter­nal inves­tors have contri­bu­ted over EUR 1.9 billion to the HTGF port­fo­lio via around 1,400 follow-on finan­cing rounds.
www.high-tech-gruenderfonds.de

About MII Mulcan Inter­na­tio­nal Investments 
MULCAN is an inter­na­tio­nal invest­ment company focu­sed on growth invest­ments in the manu­fac­tu­ring, indus­trial and service sectors throug­hout Europe (with a parti­cu­lar empha­sis on Eastern Europe), the Middle East and other deve­lo­ping countries.
www.mulcan.de

About Vesa­lius Bioca­pi­tal Part­ners S.à r.L
Vesa­lius Bioca­pi­tal (Vesa­lius), the specia­li­zed life scien­ces venture capi­tal inves­tor, has been support­ing human health compa­nies through venture capi­tal funds since 2007. Since its incep­tion, Vesa­lius has raised over 260 million euros in three funds and contri­bu­ted to the deve­lo­p­ment of over 25 compa­nies. The invest­ment port­fo­lio is balan­ced between invest­ments in drug deve­lo­p­ment and invest­ments in non-drug deve­lo­p­ment. In addi­tion, Vesa­lius is commit­ted to provi­ding capi­tal to science-backed inno­va­tion and ambi­tious entre­pre­neurs, with a focus on an exit within five years. www.vesaliusbiocapital.com

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at] fyb.de

Send email